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Abstract 
Intracellular redox environment, the relative amount of oxidized and reduced chemical 
species within a cell, is important in regulating cellular processes; however, molecular 
mechanisms that mediate redox environment are poorly understood largely because of 
limitations of tools to both modulate and measure the intracellular redox environment. For 
example, pharmacological methods that modulate intracellular redox environment often lack 
selectivity, cause cellular toxicity, and perturb intracellular homeostasis. Methods for 
monitoring intracellular redox environment can also cause toxicity and protocols typically 
require disruption of cells. The overall goal of my dissertation research therefore was to 
develop and validate tools for both modulating and measuring the intracellular redox 
environment. 
 This dissertation describes the development of three-electrode electrochemical platforms 
to modulate the intracellular redox environment of mammalian cells. The platforms are 
capable of both oxidizing and reducing the intracellular redox environment of Chinese 
hamster ovary (CHO) cells in correspondence to applied extracellular potential. I also 
demonstrate the utility of novel FRET-based biosensors, developed by collaborators, as real-
time indicators of reduction/oxidation conditions in CHO and isogenic porcine fibroblasts. 
These studies will help unravel the role of redox regulation in many biological processes 
including those connected to normal and tumorigenic cells. 
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Chapter 1 
1.1 General Introduction 
The progression of many biological processes such as cell cycle progression (1), cellular 
growth (2), and processes related to the onset and progression of diseases such as cancer (3) 
depends on the intracellular redox environment in which the process takes place (4-6).  
Although redox state is important in regulating cellular processes the exact role of redox state 
change or regulation in each of these processes is not very well understood. The precise 
effects that changes in the intracellular redox state have on response pathways, signaling 
pathways, genetic responses and cell fate outcomes, especially in the range of normal 
oxidative stress levels, needs to be unraveled (7). 
Redox state is systematically regulated in normal, non-transformed, cells (8). However, 
in tumor cells, although redox state is a key player in cell function, redox regulation as it 
occurs in healthy, non-transformed cells appears to be lost (9-11). Further investigations are 
needed to unravel the role of redox state in influencing the cell fate of cancerous cells.  The 
key question that remains is: To what extent have tumor cells lost the ability to mount 
or sense changes in intracellular redox state?  
For these types of studies, pharmacological methods are the most widely spread methods 
used to modulate the intracellular redox environment of cultured cells (12), however, they  
are often limited. Unfortunately, these approaches lack selectivity (13) and often exert 
cellular toxicity. Furthermore, necessary medium replacements also disturb intracellular 
homeostasis. 
To further understand the key research question, I have employed the use of two „tools‟ 
(1) electrochemical platforms to modulate intracellular redox environment; and 
(2) a novel FRET-based biosensor for measuring intracellular redox environment. 
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These tools, developed by myself and collaborators, have also been coupled with more 
traditional methods such as flow cytometry, fluorescent microscopy, and high performance 
liquid chromatography/ mass spectrometry (HPLC-MS/MS) for qualitative determination of 
intracellular redox state, visualization of intracellular redox environment, and quantitative 
measurement of intracellular redox state of different cell types, respectively. Also, I have 
transfected genetically isogenic porcine 161 cells (14), with FRET-based biosensors for their 
validation via experiments aimed at comparing the response of normal cells that experience 
contact inhibition verses tumorigenic cells that do not experience this phenomenon to 
modulation in redox state.   
The subsequent chapters of this dissertation will describe the tools that I have developed 
as well as the results that have been obtained with these tools to further advance 
understanding of the role of intracellular redox in cellular processes and to provide new 
methodologies for future studies in this promising field. Chapter 2 is comprised of a literature 
review of the importance of the glutathione/glutathione disulfide (GSH/GSSG) redox couple 
as an indicator of redox state and redox regulation. Chapter 3 describes the development and 
validation of electrochemical platforms to modulate intracellular redox state. Chapter 4 
describes the characterization (shape, cell growth, volume, and redox state) of model 
isogenic 161 porcine cells, both normal, non-transformed, healthy cells and transformed, 
tumorigenic cells. Chapter 5 briefly describes the validation of FRET-based biosensors in 
live cells, conducted by my collaborators, using the CHO and 161 porcine cells.  Finally, 
Chapter 6 summarizes my findings. 
1.2 References 
1. Conour, J. E., Graham, W. V., and Gaskins, H. R. (2004) A combined in 
vitro/bioinformatic investigation of redox regulatory mechanisms governing cell 
cycle progression, Physiological Genomics 18, 196-205. 
2. Smith, J., Ladi, E., Mayer-Proschel, M., and Noble, M. (2000) Redox state is a central 
modulator of the balance between self-renewal and differentiation in a dividing glial 
precursor cell, Proceedings of the National Academy of Sciences of the United States 
of America 97, 10032-10037. 
3. Halliwell, B. (2007) Oxidative stress and cancer: have we moved forward?, 
Biochemical Journal 401, 1-11. 
 3 
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Biology and Medicine 30, 1191-1212. 
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Chapter 2 
The Importance of the GSH/GSSG Redox Couple in 
Intracellular Redox Regulation 
2.1 Intracellular Oxidative Stress: ROS, Free Radicals, and Other Sources 
Within biological cells, reactive oxygen species (ROS) arise as natural byproducts of 
cellular metabolism (1). For example, partial reduction of molecular oxygen (O2) results in 
production of superoxide and hydrogen peroxide (2). Superoxide (O2
·-
) and hydrogen 
peroxide (H2O2) react with transition metal ions such as cuprous and ferrous ions through 
Fenton and Haber-Weiss chemistry, producing the hydroxyl radical, HO
•
 which is highly 
reactive (4). ROS are generated in multiple compartments and by a number of enzymes 
within the cell. Important enzymes  include proteins within the plasma membrane, such as 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (5-8) as well as the a 
variety of cytosolic enzymes such as cyclooxygenases (3). Although there are a number of 
causes of reactive oxygen production in cells, most cellular ROS (approximately 90%) is 
formed in the mitochondria (3, 9).   
Mitochondrial ROS is produced as result of oxidative phosphorylation, a process that 
uses the oxidation of NADH or flavin adenine dinucleotide (FADH) to generate a potential 
energy for protons across the mitochondrial inner membrane. This potential energy in turn is 
used to phosphorylate ADP via the F1-F0 ATPase. At several locations along the cytochrome 
chain, electrons resulting from NADH or FADH can directly react with oxygen or other 
electron acceptors and generate free radicals (3) (Figure 2.1). Free radicals continuously 
“leak” from the mitochondria as ATP is produced (10). A free radical is any species capable 
of independent existence that contains one or more unpaired electrons. Other causes of 
cellular oxidative stress include transition metals such as iron and copper, ultraviolet 
radiation, γ-radiation, inflammation, chemicals such as carbon tetrachloride, smoking, 
exhausts of diesel engines and anti-cancer drugs such as adriamycin and bleomycin (11, 12).  
Free radicals attack deoxyribonucleic acid (DNA), proteins, membrane lipids, and 
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mitochondria (9). The reaction of DNA with free radicals has been extensively studied.  The 
reactions include strand breaks, base modifications and DNA-protein cross-links (10).  
Organisms are equipped with elaborate mechanisms to avoid or correct such problems (13). 
ROS were traditionally thought to be harmful to cells, tissues and organisms because they 
damage cellular macromolecules; however, in recent years, numerous studies have shown 
that ROS can function as signaling molecules that regulate cellular processes, including 
proliferation (14-17). This dual capability of ROS may be due to the differences in their 
dose-response and sub-cellular localization (18). For example, a report by Laurent et al. 
demonstrated that H2O2 regulated both proliferation and cell death (18). NIH3T3 fibroblasts 
treated with 0.02-0.13 μM hydrogen peroxide enhanced proliferation, whereas treatment with 
0.25-2 μM hydrogen peroxide or other compounds such as BSO resulted in growth arrest and 
Figure 2.1. A Schematic Model of ROS Generation in the Mitochondria.  The major production sites of superoxide 
anions at sites I and III are identified along with the major ROS scavenging pathways. Antioxidant enzymes include 
various isoforms of peroxiredoxin (Prx), superoxide dismutase (SOD), and glutathione peroxidase (GP).  The 
scavenging reaction of the peroxiredoxin family requires other cellular dithiol proteins such as thioredoxin (TrxS2).  
Similarly, the enzymatic action of GP requires reduced glutathione (GSH).  Specific family members of SOD, GP, 
and Prx are found inside the mitochondria, while other family members are localized in the cytosol or extracellular 
space. The different complexes of oxidative phosphorylation are color coded with regard to the magnitude of Eox for 
reducing oxygen, with red (dehydrogenases [DH] and site I) having the highest potential and pink (site IV) the 
lowest potential. The family of uncoupling proteins (UCP), here denoted in green, reduces the overall mitochondrial 
membrane potential (ΔΨ).  This is believed to result in a generalized decrease in Eox for both sites I and III and 
hence a reduction in ROS formation (3). 
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cell death.  Therefore, higher levels of ROS could be toxic, while low levels or ROS are 
necessary for proper functioning or cellular processes including proliferation (18). 
2.2 Antioxidant Systems 
To help eliminate the potentially harmful effect of ROS, cells have developed 
sophisticated antioxidant defense systems including: enzymes (19), small molecular weight 
non-enzymatic antioxidants such as: cysteine, GSH, vitamins C and E (ascorbic acid and α-
tocopherol) (20); and enzymatic antioxidant defenses, such as scavenger enzymes superoxide 
dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), and glutathione reductase 
(GR) (21). The major contributors to total cellular thiol pools include the 
thioredoxin/thioredoxin reductase, cysteine/cystine and the glutathione/glutathione disulfide 
couples (22, 23). An entire range of interconnected mechanisms between these redox 
couples, often localized to different compartments within the cell, regulates the potential at 
these different locations, as will be explained further below. 
2.2.1 Enzymes and Proteins 
Among other thiol sensitive enzymes and proteins, there are three superoxide dismutases.  
Superoxide dismutases differ based upon their active site metal cofactors and/or cellular 
localization: SOD1 (CuZnSOD, cytosolic); SOD2 (MnSOD, intra-mitochondrial); and SOD3 
(CuZnSOD, extracellular) (24). Each enzyme catalyzes a reaction that helps convert O2
·-
 to 
hydrogen peroxide, which is more stable and less reactive. The produced hydrogen peroxide 
can however react with Fe
2+
 or Cu
2+
 in the Fenton reaction to produce the highly toxic OH
·
. 
In turn, catalases with heme groups in their active site help catalyze the conversion of 
hydrogen peroxide to water (25). 
Thioredoxin was first discovered in 1964 by Laurent et al. in Escherichia coli and later in 
mammals in 1967 (26, 27). Thioredoxin reduces cystine moieties in the DNA-binding sites of 
several transcription factors and is therefore important in gene expression (28, 29).  
Intracellular concentrations of thioredoxin range from approximately 1 to 10 mM in bovine 
tissue (30) and up to 15 mM in bacteria (30). The thiols of mammalian thioredoxin serve as 
electron donors for ribonucleotide reductase as well as for methionine sulfoxide reductase. It 
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also facilitates the refolding of disulfide-containing proteins and regulates the DNA binding 
activity of some transcription factors (31). There are three well known families of 
thioredoxin proteins (Trx-1, Trx-2 and human Trx-like p32 protein) which are involved in the 
production of intra-molecular disulfides (32). The reduction of the disulfide back to the 
dithiol form is catalyzed by thioredoxin reductase, the source of electrons being NADPH  
(33, 34). 
2.2.2 The Cysteine / Cystine Redox Couple Cys/CySS 
The amino acid cysteine (Cys), its disulfide, cystine (CySS), GSH, and glutathione 
disulfide (GSSG) are the major low-molecular weight anti-oxidant species within 
mammalian cells (23, 35). These redox couples are compartmentalized and not necessarily in 
equilibrium with each other (36). The redox states of the cysteine/cystine and the GSH/GSSG 
couples have distinct regulatory functions (35-37). Cys/CySS for example, in the culture 
medium of lung fibroblasts, stimulated proliferation and expression of transitional matrix 
components such as fibronectin in the absence of apparent changes to the GSH pool (38). 
2.3 The Glutathione / Glutathione Disulfide Redox Couple GSH/GSSG 
Glutathione (L-γ-glutamyl-L-cysteinyl-glycine) is a tripeptide, a non-protein sulfhydryl 
molecule present in both prokaryotes and eukaryotes and it is the principle non-protein thiol 
Figure 2.2. A schematic of cysteine and cystine. The amino acid cysteine and its disulfide, cystine are two of the 
major low-molecular weight species within cells. Cystine is formed by the oxidation of two cysteines characterized 
by the disulfide bond. 
Cysteine 
Cystine 
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component of the antioxidant defense system in living cells (38, 39) (Figure 2.3). GSH is 
synthesized from L-glutamate, L-cysteine, and glycine in two consecutive steps, catalyzed by 
γ-glutamyl-cysteine synthase and glutathione synthase (now commonly referred to as 
glutamate cysteine ligase, GCL) (40). Mostly found in its reduced form (41), GSH is 
considered the major cellular thiol “redox buffer” because of its concentrations within the 
cytosol. On average, the GSH concentration in the cytosol is 1–11 mM (42).  
The main function of glutathione is to protect cells from the damaging effects of 
hydroperoxides formed during normal metabolism (41). GSH is virtually produced in all 
organs, especially in the liver, and present in all mammalian tissues (43). GSH protects cells 
from toxins such as free radicals by acting as an electron donor thus reducing any disulfide 
bonds formed within cytoplasmic proteins to cysteines (43).  GSH reacts spontaneously with 
a number of ROS as well as other cytotoxic products including OH
·
, peroxynitrite (ONOO
-
), 
Figure 2.3. A schematic of glutathione and glutathione disulfide. Glutathione is considered the major cellular redox 
buffer because of its concentrations in the cytosol. Glutathione disulfide is derived from two glutathione molecules. 
glutathione 
glutathione disulfide 
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and dinitrogen trioxide (N2O3) (44-46). GSH is also used as a substrate for directed 
antioxidant/toxin interactions for a number of enzymes including GSH peroxidase (47, 48) 
and GSH transferase (GSTs) (49).  The oxidized form of the redox couple, GSSG, can be 
reduced back to GSH by glutathione reductase, at the cost of NADPH, and also by the 
thioredoxin or glutaredoxin systems. The GSH/GSSG ratio is often used as an indicator of 
modulations in intracellular redox state (22, 50). 
2.4 Intracellular Redox State 
Intracellular redox state [the ratio of reduced to oxidized glutathione (GSH/GSSG) within 
cells] is often used as a measure of cellular toxicity or vice versa as a predictor of the 
antioxidative capacity of the cells (51). Much work has been conducted on ROS and its 
effects on cell cycle progression and other cellular functions; however, fewer reports have 
been made on the active role of glutathione and other antioxidants in cellular defense 
mechanisms during the cell cycle (52) specifically in the range of normal GSH/GSSG ratios.  
Because cellular redox state is the balance between levels of reactive oxygen species and the 
antioxidants that scavenges them, both qualitative and quantitative measurements provide 
useful information about redox regulation of cellular events.   
A number of qualitative methods which typically use redox active dyes to measure 
intracellular GSH and/or ROS (53, 54) are available; however, these methods are often 
limited in specificity (55). Quantitative techniques (“e.g.” HPLC-MS/MS), which typically 
disrupt cellular integrity, have also been developed (56). For quantitative studies the Nernst 
Equation has been used (22). The Nernst equation allows one to determine the voltage of an 
electrochemical cell (ΔE) taking the Gibbs energy change (ΔG) and the reaction quotient (Q) 
into account. The Nernst equation has broad applications in biology because much of biology 
involves electron transfer reactions. The Nernst equation for the GSH/GSSG redox couple is 
expressed as: Eh = Eo + RT/nF ln [GSSG]/[GSH]
2
, where Eh is the half-cell reduction 
potential; Eo is the reduction potential at standard conditions; R is the gas constant (R= 8.314 
J K
-1
 mol
-1
); T is the temperature in Kelvin; and F is the Faraday constant (F = 9.6485 x 10
4
 
C mol
-1
).  In subsequent chapters, I used the Nernst equation to determine the redox potential 
of Chinese hamster ovary (CHO) (Chapter 3) and 161 porcine cells (Chapter 4). Here the 
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redox potential for the GSH/GSSG couple is calculated using the Nernst equation in the form 
Eh = -252 mV- (61.5/2)log ([GSH]
2
 / [GSSG])] at 37°C and pH 7.2 (22).  
2.5 Redox State and Cellular Processes 
Redox state is important in a number of cellular processes including: differentiation and 
apoptosis (1, 22), gene expression (57, 58), tumorigenesis (59) and cell death (52). Here I 
focus on the importance of redox environment in normal cell cycle regulation, cell growth 
and abnormal cell proliferation.   
Cellular proliferation is subject to tightly regulated biochemical and genetic pathways, 
the loss of which can yield abnormal proliferation (1). Proliferation depends both upon cell 
division and cell death. Cell division drives proliferation, and cell death prevents damaged 
cells from propagating damaged cellular macromolecules to daughter generations. The 
mammalian cell cycle has five distinct phases; quiescence (G0), gap phase 1 (G1), synthesis 
phase (S), gap phase 2 (G2), and mitosis (M), all of which are influenced by cellular redox 
status- evidence suggests a redox cycle which regulates the cell cycle. For example, 
superoxide dismutases 2 (MnSOD) enzyme activity in NIH3T3 cells decreased during the S 
phase compared to G0. Cells exhibiting contact inhibition showed higher superoxide 
dismutases (SOD) levels when proliferation stopped, whereas cells not demonstrating 
density-dependent growth inhibition did not exhibit increased SOD levels (70, 71). 
Modulation of other antioxidant enzymes also affects proliferation rates. Catalase over-
expression in vascular smooth muscle cells inhibits proliferation and increases the apoptotic 
rate, indicating that H2O2 not only regulates proliferation but also survival (72). Over 
expression of phospholipid-hydroperoxide glutathione peroxidase (PhGPx) inhibits 
progression from G1 to S, suggesting the possible involvement of lipid peroxidation-
mediated signaling in cell cycle progression (73). 
The intracellular redox environment changes as cells progress through the cell cycle (74, 
75). For example, Conour et al. indicated that GSH content was significantly higher in the 
G2+M phase compared to the G1 phase, suggesting that cells in the G2+M phase are more 
reduced than cells in the G1 phase (74). Other researchers have suggested that [GSH] are 
greater during the exponential growth phase and then decrease as cells become confluent and 
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begin to differentiate (50, 76). Attene-Ramos et al. showed that (i) normal, intestinal 
epithelial cells (IEC-6) become contact inhibited after 9 days in culture; and (ii) 
concentrations of GSH and GSSG change during the stages of cell growth as exhibited by the 
calculated redox potential, and thus also cell growth, concentrations of intracellular 
antioxidants and intracellular redox potential change. Attene-Ramos et al. also showed that 
calculated redox potential peaks prior to confluence, C, and reduces thereafter (Figure 2.4), 
suggesting that change in redox and/or redox regulation is involved in cell cycle progression 
(77).   
Hutter et al. also showed that the redox potential of normal proliferating cells was more 
reducing (by more than 34 mV) than 100% confluent, contact inhibited cells (78).  
Specifically, the redox potential of sparsely seeded normal fibroblasts was -222 mV while 
contact inhibited cells exhibited a redox potential of -188 mV. Redox regulation seen in 
“normal” cells is thought to be nano-switch or trigger driven (Figure 2.5) (22).  Schafer et al. 
postulate that during proliferation Ehc for the GSSG/2GSH couple has the most negative 
value.  (A) The switches for proliferation are fully on.  (B) When Ehc (GSH) becomes more 
Figure 2.4. Stages of cell growth (growth curve) and the redox potential (Eh) of the GSSG/2GSH couple 
calculated with the Nernst equation and [GSH] and [GSSG]. The couple became reduced from day 1 to day 
3 (–35 mV) and then started to become more oxidized after confluence (C). The couple was significantly 
more reduced on day 3 (**P < 0.01) and more oxidized after day 9, when proliferation decreased because 
of contact inhibition (Ci), compared with other days (*P < 0.01). [Adopted from (77)]. 
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positive, the differentiation switches can be turned on while proliferation decreases.  (C) The 
more positive (reducing) Ehc (GSH) becomes, the more differentiation switches are turned on 
until they reach a maximum where nearly all cells are differentiating.  (D) While cells 
undergo differentiation, proliferation switches are turned down and finally turned off.  Cells 
that are not terminally differentiated could undergo proliferation with an appropriate signal 
and associated redox environment.  If Ehc (GSH) becomes too positive, then death signals are 
activated and apoptosis is initiated.  This mechanism provides for the orderly removal of 
cells that have lost their ability to control their redox environment and therefore, are not 
functioning normally.  It should also coincide with signaling pathways to purposely dispose 
of unneeded cells.  (F) Very high values of Ehc (GSH), resulting from severe oxidative stress, 
leave only necrosis as a path to cell death (22).  This type of controlled or nano-switch 
regulation is thought to be perturbed in tumorigenesis. 
2.6 Tumorigenesis 
Tumorigenesis can be divided into three distinct stages: initiation, promotion, and 
progression.  Initiation can occur because of mutations in one or more genes, which result in 
loss or gain of function (see Chapter 4).  Promotion is the functional enhancement and 
alteration of the pathway induced by initiation.  Progression is the continuing change of the 
unstable karyotype, often leading to aberrant proliferation.  
Figure 2.5. Reduction potential-driven nano-switches move cells through different biological stages. The 
redox environment of a cell changes throughout its life cycle. When redox potentials are most reduced 
(negative) switch for proliferation dominate. As potentials become more oxidized switches for differentiation 
are triggered. Further oxidation results in apoptosis or necrosis in severe oxidative stress [Adopted from (22)]. 
S
w
it
c
h
 S
ta
tu
s
on
off
Intracellular Redox Potential: E(mV) - +
S
w
it
c
h
 S
ta
tu
s
 13 
According to Sarsour et al. aberrant proliferation in cancer cells could be due to a loss in 
the redox regulation of the cell cycle (79). 
Redox regulation is a key player in the overall mechanisms of tumorigenesis (3, 39, 49, 
80, 81), yet the type of “controlled redox regulation” observed in normal cells does not exist 
or has not yet been fully elucidated (82). Figure 2.6 outlines the role of reactive oxygen 
species and cellular antioxidant systems in cancer cell progression. Upregulation of ROS 
instigates an upregulation of antioxidant defense mechanisms. Propagation of response 
pathways results in a characteristic tumorigenic cell outcomes such as oncogenic activation, 
genomic instability, chemotherapeutic resistance or metastasis (10). 
Also, although GSH is needed to combat carcinogens, it was first observed in 1987 in 
melphalan-resistant murine L1210 cells (83) that elevated levels of GSH make tumors more 
resistant to chemo and radiotherapy (84-86). Since then, GSH levels have been shown to be 
elevated in a number of different human cancer tissues including bone marrow (87); breast 
(88); colon (89); and lung (90). Hutter et al. demonstrated that the redox potential of 
fibrosarcoma cells did not exhibit modulation in redox state (91) remaining steadily between 
Figure 2.6. Schematic outline of the role or reactive oxygen species in cancer. Downregulation of antioxidant 
enzymes results in accumulation of cellular reactive oxygen species (ROS-hydrogen peroxide, superoxide). 
Cellular ROS initiate protein damage, DNA damage, and increased nuclear response. The results of responses 
include oncogenic activity, chemotherapy resistance, and metastasis [adopted from (10)].  
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-209 and -213 mV. Hoffman et al. suggest that there is some type of threshold redox potential 
that allows for the dephosphorylation of certain regulatory proteins; if this threshold redox 
potential is never reached, cells continue to proliferate and cannot enter G0 (92). 
There have also been somewhat contradictory reports that suggest that cells produce more 
ROS rather than reduced species (e.g. GSH) as they proliferate. For example, Havens et al. 
showed that with synchronized T98G cells, the production of ROS increased during the cell 
cycle, peaking in G2/M phase (93). Limoli et al. also showed that the level of ROS in neural 
precursor cells is dependent upon cell density and is characterized by ROS being about 4-fold 
higher in sparsely seeded (proliferating) cells rather than densely seeded cells. This trend was 
also observed in mouse embryonic fibroblasts and primary human fibroblasts. However, 
Limoli also demonstrated that immortalized mouse neural precursor, HeLa and CHO cells 
exhibit the opposite behavior (i.e. as density increased the amount of ROS increased) 
suggesting that sparsely seeded cells are more reduced (94).  A large number of cancer cell 
lines have been found to produce more hydrogen peroxide than non-cancer cell lines (95). In 
prostate cancer cells, inhibition of ROS generation with antioxidants increased apoptosis 
(96).  Anatomic pathologists have demonstrated in autopsy cases that the morphology of 
cancer cells is well preserved even if other kinds of cells have severe autolytic changes.  This 
suggests that cancer cells are relatively resistant to oxidative stress (10). These types of 
contradictory findings highlight the complexity of my research problem. Researchers must be 
aware that various conclusions are often based upon specific treatment conditions, cell type 
and method of measurement of redox state. Previous work suggests that the adaptive 
response to an oxidative stress varies from one cell line to another (97, 98). Nevertheless, 
results suggest involvement of redox environment in normal growth control and tumorigenic 
cell progression (78). 
2.7 Concluding Remarks 
In this chapter, some key findings from the literature with respect to the importance of 
intracellular redox regulation or changes in cellular processes were summarized.  Although 
the role of redox regulation in the mechanisms of normal and tumorigenic cells is an 
interesting and important topic, further investigations are needed to unravel the exact role of 
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redox regulation in determining cell fate.  The key question still remains: to what extent 
have tumor cells lost the ability to either mount or sense changes in intracellular redox 
potential? Addressing this question more systematically and globally, for example, 
observing the interplay of cellular parameters including: redox status, antioxidant enzymes 
expression, cell signaling and transcription factor activation profiles will be key in 
understanding the role of redox environment in diseases such as cancer.  This question is 
addressed further in Chapter 4.  First, Chapter 3 describes the creation of an engineered 
microscale platform to oxidize or reduce cells in a controlled fashion. 
2.8 References 
1. Menon, S. G., and Goswami, P. C. (2007) A redox cycle within the cell cycle: ring in 
the old with the new, Oncogene 26, 1101-1109. 
2. Halliwell, B. (1999) Oxygen and nitrogen are pro-carcinogens, Damage to DNA by 
reactive oxygen, chlorine and nitrogen species: measurement, mechanism and the 
effects of nutrition, Mutation Research-Genetic Toxicology and Environmental 
Mutagenesis 443, 37-52. 
3. Balaban, R. S., Nemoto, S., and Finkel, T. (2005) Mitochondria, oxidants, and aging, 
Cell 120, 483-495. 
4. Halliwell, B., and Gutteridge, J. M. C. (1992) Biologically relevant metal ion-
dependent hydroxyl radical generation- an update, FEBS Letters 307, 108-112. 
5. Lambeth, J. D. (2004) Nox enzymes and the biology of reactive oxygen, Nature 
Reviews Immunology 4, 181-189. 
6. Schrader, M., and Fahimi, H. D. (2004) Mammalian peroxisomes and reactive 
oxygen species, Histochemistry and Cell Biology 122, 383-393. 
7. Zangar, R. C., Davydov, D. R., and Verma, S. (2004) Mechanisms that regulate 
production of reactive oxygen species by cytochrome P450, Toxicology and Applied 
Pharmacology 199, 316-331. 
8. Klebanoff, S. J. (2005) Myeloperoxidase: friend and foe, Journal of Leukocyte 
Biology 77, 598-625. 
9. Victor, V. M., Esplugues, J. V., Hernandez-Mijares, A., and Rocha, M. (2009) 
Oxidative stress and mitochondrial dysfunction in sepsis: a potential therapy with 
mitochondria-targeted antioxidants, Infectious Disorders - Drug Targets 9, 376-389. 
10. Toyokuni, S. (1998) Oxidative stress and cancer: The role of redox regulation, 
Biotherapy 11, 147-154. 
11. Halliwell, B. (1989) Tell me about free-radicals, doctor- a review, Journal of the 
Royal Society of Medicine 82, 747-752. 
 16 
12. Halliwell, B. (1989) Free Radicals, Reactive Oxygen Species and Human-Disease- A 
critical-evaluation with special reference to atherosclerosis, British Journal of 
Experimental Pathology 70, 737-757. 
13. Modrich, P. (1991) Mechanisms and biological effects of mismatch repair, Annual 
Review of Genetics 25, 229-253. 
14. Werner, E., and Werb, Z. (2002) Integrins engage mitochondrial function for signal 
transduction by a mechanism dependent on Rho GTPases, The Journal of Cell 
Biology 158, 357-369. 
15. Dada, L. A., Chandel, N. S., Ridge, K. M., Pedemonte, C., Bertorello, A. M., and 
Sznajder, J. I. (2003) Hypoxia-induced endocytosis of Na,K-ATPase in alveolar 
epithelial cells is mediated by mitochondrial reactive oxygen species and PKC-zeta, 
Journal of Clinical Investigation 111, 1057-1064. 
16. Bartosz, G. (2009) Reactive oxygen species: Destroyers or messengers?, Biochemical 
Pharmacology 77, 1303-1315. 
17. Clerkin, J. S., Naughton, R., Quiney, C., and Cotter, T. G. (2008) Mechanisms of 
ROS modulated cell survival during carcinogenesis, Cancer Letters 266, 30-36. 
18. Laurent, A., Nicco, C., Chereau, C., Goulvestre, C., Alexandre, J., Alves, A., Levy, 
E., Goldwasser, F., Panis, Y., Soubrane, O., Weill, B., and Batteux, F. (2005) 
Controlling tumor growth by modulating endogenous production of reactive oxygen 
species, Cancer Research 65, 948-956. 
19. Kalpakcioglu, B., and Senel, K. (2008) The interrelation of glutathione reductase, 
catalase, glutathione peroxidase, superoxide dismutase, and glucose-6-phosphate in 
the pathogenesis of rheumatoid arthritis, Clinical Rheumatology 27, 141-145. 
20. Di Mascio, P., Murphy, M. E., and Sies, H. (1991) Antioxidant defense systems- the 
role of carotenoids, tocopherols, and thiols, American Journal of Clinical Nutrition 
53, S194-S200. 
21. Halliwell, B. (2007) Oxidative stress and cancer: have we moved forward?, 
Biochemical Journal 401, 1-11. 
22. Schafer, F. Q., and Buettner, G. R. (2001) Redox environment of the cell as viewed 
through the redox state of the glutathione disulfide/glutathione couple, Free Radical 
Biology and Medicine 30, 1191-1212. 
23. Jones, D. P., Go, Y. M., Anderson, C. L., Ziegler, T. R., Kinkade, J. M., and Kirlin, 
W. G. (2004) Cysteine/cystine couple is a newly recognized node in the circuitry for 
biologic redox signaling and control, The FASEB Journal 18, 1246-+. 
24. Fridovich, I. (1995) Superoxide radical and superoxide dismutases, Annual Review of 
Biochemistry 64, 97-112. 
25. Chance, B., Sies, H., and Boveris, A. (1979) Hydroperoxide metabolism in 
mammalian organs, Physiological Reviews 59, 527-605. 
 17 
26. Laurent, T. C., Moore, E. C., and Reichard, P. (1964) Enzymatic synthesis of 
deoxyribonucleotides.4. isolation + characterization of thioredoxin hydrogen donor 
from Escherichia Coli B, Journal of Biological Chemistry 239, 3436-&. 
27. Moore, E. C. (1967) A thioredoxin-thioredoxin reductase system from rat tumor, 
Biochemical and Biophysical Research Communications 29, 264-&. 
28. Matthews, J. R., Wakasugi, N., Virelizier, J. L., Yodoi, J., and Hay, R. T. (1992) 
Thioredoxin regulates the DNA-binding activity of NF-CHI-B by reduction of a 
disulfide bond involving cysteine 62, Nucleic Acids Research 20, 3821-3830. 
29. Okamoto, T., Ogiwara, H., Hayashi, T., Mitsui, A., Kawabe, T., and Yodoi, J. (1992) 
Human thioredoxin adult T-Cell leukemia-driven factor activates the enhancer 
binding-protein of human-immunodeficiency-virus type-1 by thiol redox control 
mechanism, International Immunology 4, 811-819. 
30. Holmgren, A., and Luthman, M. (1978) Tissue distribution and subcellular-
localization of bovine thioredoxin determined by radioimmunoassay, Biochemistry 
17, 4071-4077. 
31. Sen, C. K. (1998) Redox signaling and the emerging therapeutic potential of thiol 
antioxidants, Biochemical Pharmacology 55, 1747-1758. 
32. Powis, G., and Montfort, W. R. (2001) Properties and biological activities of 
thioredoxins, Annual Review of Biophysics and Biomolecular Structure 30, 421-455. 
33. Luthman, M., and Holmgren, A. (1982) Rat-liver thioredoxin and thioredoxin 
reductase- purification and characterization, Biochemistry 21, 6628-6633. 
34. Lee, S. R., Bar-Noy, S., Kwon, J., Levine, R. L., Stadtman, T. C., and Rhee, S. G. 
(2000) Mammalian thioredoxin reductase: Oxidation of the C-terminal 
cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium 
with sulfur markedly reduces catalytic activity, Proceedings of the National Academy 
of Sciences of the United States of America 97, 2521-2526. 
35. Jones, D. P. (2006) Redefining oxidative stress, Antioxidants & Redox Signaling 8, 
1865-1879. 
36. Jones, D. P., Go, Y. M., and Kemp, M. (2008) Redox systems biology: is there a 
redox code?, Free Radical Research 42, S29-S29. 
37. Jones, D. P. (2008) Radical-free biology of oxidative stress, American Journal of 
Physiology-Cell Physiology 295, C849-C868. 
38. Meister, A. (1984) New aspects of glutathione biochemistry and transport--selective 
alteration of glutathione metabolism, Nutrition Reviews 42, 397-410. 
39. Pastore, A., Federici, G., Bertini, E., and Piemonte, F. (2003) Analysis of glutathione: 
Implication in redox and detoxification, Clinica Chimica Acta 331, 19-39. 
40. Griffith, O. W. (1999) Biologic and pharmacologic regulation of mammalian 
glutathione synthesis, Free Radical Biology and Medicine 27, 922-935. 
 18 
41. Droge, W., Schulzeosthoff, K., Mihm, S., Galter, D., Schenk, H., Eck, H. P., Roth, S., 
and Gmunder, H. (1994) Function of glutathione and glutathione disulfide 
immunology and immunopathology, FASEB Journal 8, 1131-1138. 
42. Gilbert, H. F. (1990) Molecular and cellular aspects of thiol disulfide exchange, 
Advances in Enzymology and Related Areas of Molecular Biology 63, 69-172. 
43. Perricone, C., de Carolis, C., and Perricone, R. (2009) Glutathione: A key player in 
autoimmunity, Autoimmunity Reviews 8. 
44. Kalyanaraman, B., Karoui, H., Singh, R. J., and Felix, C. C. (1996) Detection of thiyl 
radical adducts formed during hydroxyl radical- and peroxynitrite-mediated oxidation 
of thiols - A high resolution ESR spin-trapping study at Q-band (35 GHz), Analytical 
Biochemistry 241, 75-81. 
45. Briviba, K., Klotz, L. O., and Sies, H. (1999) Defenses against peroxynitrite, Nitric 
Oxide, Pt C 301, 301-311. 
46. Luperchio, S., Tamir, S., and Tannenbaum, S. R. (1996) NO-induced oxidative stress 
and glutathione metabolism in rodent and human cells, Free Radical Biology and 
Medicine 21, 513-519. 
47. Arteel, G. E., and Sies, H. (2001) The biochemistry of selenium and the glutathione 
system, Environmental Toxicology and Pharmacology 10, 153-158. 
48. Fahey, R. C., and Sundquist, A. R. (1991) Evolution of glutathione metabolism, 
Advances in Enzymology and Related Areas of Molecular Biology 64, 1-53. 
49. Townsend, D. M., and Tew, K. D. (2003) The role of glutathione-S-transferase in 
anti-cancer drug resistance, Oncogene 22, 7369-7375. 
50. Nkabyo, Y. S., Ziegler, T. R., Gu, L. H., Watson, W. H., and Jones, D. P. (2002) 
Glutathione and thioredoxin redox during differentiation in human colon epithelial 
(Caco-2) cells, American Journal of Physiology-Gastrointestinal and Liver 
Physiology 283, G1352-G1359. 
51. Nel, A., Xia, T., Madler, L., and Li, N. (2006) Toxic potential of materials at the 
nanolevel, Science 311, 622-627. 
52. Markovic, J., Mora, N. J., Broseta, A. M., Gimeno, A., de-la-Concepcion, N., Vina, 
J., and Pallardo, F. V. (2009) The depletion of nuclear glutathione impairs cell 
proliferation in 3t3 fibroblasts, PLoS ONE 4. 
53. Hedley, D. W., and Chow, S. (1994) Evaluation of methods for measuring cellular 
glutathione content using flow-cytometry, Cytometry 15, 349-358. 
54. Webb, C., Bedwell, C., Guth, A., Avery, P., and Dow, S. (2006) Use of flow 
cytometry and monochlorobimane to quantitate intracellular glutathione 
concentrations in feline leukocytes, Veterinary Immunology and Immunopathology 
112, 129-140. 
55. Gutscher, M., Pauleau, A. L., Marty, L., Brach, T., Wabnitz, G. H., Samstag, Y., 
Meyer, A. J., and Dick, T. P. (2008) Real-time imaging of the intracellular 
glutathione redox potential, Nature Methods 5, 553-559. 
 19 
56. Bouligand, J., Deroussent, A., Paci, A., Morizet, J., and Vassal, G. (2006) Liquid 
chromatography-tandem mass spectrometry assay of reduced and oxidized 
glutathione and main precursors in mice liver, Journal of Chromatography B-
Analytical Technologies in the Biomedical and Life Sciences 832, 67-74. 
57. Arrigo, A. P. (1999) Gene expression and the thiol redox state, Free Radical Biology 
and Medicine 27, 936-944. 
58. Sen, C. K., Roy, S., and Packer, L. (1999) Fas mediated apoptosis of human Jurkat T-
cells: intracellular events and potentiation by redox-active alpha-lipoic acid, Cell 
Death and Differentiation 6, 481-491. 
59. Clairmont, A., Sies, H., Ramachandran, S., Lear, J. T., Smith, A. G., Bowers, B., 
Jones, P. W., Fryer, A. A., and Strange, R. C. (1999) Association of NAD(P)H : 
quinone oxidoreductase (NQO1) null with numbers of basal cell carcinomas: use of a 
multivariate model to rank the relative importance of this polymorphism and those at 
other relevant loci, Carcinogenesis 20, 1235-1240. 
60. Yoshida, M., and Beppu, T. (1988) Reversible Arrest of Proliferation of Rat 3Y1 
Fibroblasts in Both the G1-Phase and G2-Phase by Trichostatin-A, Experimental Cell 
Research 177, 122-131. 
61. Nunemaker, C. S., Defazio, R. A., and Moenter, S. M. (2002) Estradiol-sensitive 
afferents modulate long-term episodic firing patterns of GnRH neurons, 
Endocrinology 143, 2284-2292. 
62. Michaloglou, C., Vredeveld, L. C. W., Soengas, M. S., Denoyelle, C., Kuilman, T., 
van der Horst, C., Majoor, D. M., Shay, J. W., Mooi, W. J., and Peeper, D. S. (2005) 
BRAF(E600)-associated senescence-like cell cycle arrest of human naevi, Nature 
436, 720-724. 
63. Johnson, T. M., Meade, K., Pathak, N., Marques, M. R., and Attardi, L. D. (2008) 
Knockin mice expressing a Chimeric p53 protein reveal mechanistic differences in 
how p53 triggers apoptosis and senescence, Proceedings of the National Academy of 
Sciences of the United States of America 105, 1215-1220. 
64. Smith, J. A., and Martin, L. (1973) Do cells cycle, Proceedings of the National 
Academy of Sciences of the United States of America 70, 1263-1267. 
65. Wu, R. S., and Bonner, W. M. (1981) Separation of basal histone synthesis from S-
phase histone synthesis in dividing cells, Cell 27, 321-330. 
66. Nelson, D. M., Ye, X. F., Hall, C., Santos, H., Ma, T., Kao, G. D., Yen, T. J., Harper, 
J. W., and Adams, P. D. (2002) Coupling of DNA synthesis and histone synthesis in 
S phase independent of cyclin/cdk2 activity, Molecular and Cellular Biology 22, 
7459-7472. 
67. Cameron, I. L., and Greulich, R. C. (1963) Evidence for an essentially constant 
duration of DNA synthesis in renewing epithelia of adult mouse, The Journal of Cell 
Biology 18, 31-&. 
68. Mangone, M., Myers, M. P., and Herr, W. Role of the HCF-1 basic region in 
sustaining cell proliferation, PLoS ONE 5. 
 20 
69. Lilly, M. A., and Duronio, R. J. (2005) New insights into cell cycle control from the 
Drosophila endocycle, Oncogene 24, 2765-2775. 
70. Oberley, T. D., Schultz, J. L., Li, N., and Oberley, L. W. (1995) Antioxidant enzyme 
levels as a function of growth-state in cell-culture, Free Radical Biology and 
Medicine 19, 53-65. 
71. Li, N., and Oberley, T. D. (1998) Modulation of antioxidant enzymes, reactive 
oxygen species, and glutathione levels in manganese superoxide dismutase-
overexpressing NIH/3T3 fibroblasts during the cell cycle, Journal of Cellular 
Physiology 177, 148-160. 
72. Brown, M. R., Miller, F. J., Li, W. G., Ellingson, A. N., Mozena, J. D., Chatterjee, P., 
Engelhardt, J. F., Zwacka, R. M., Oberley, L. W., Fang, X., Spector, A. A., and 
Weintraub, N. L. (1999) Overexpression of human catalase inhibits proliferation and 
promotes apoptosis in vascular smooth muscle cells, Circulation Research 85, 524-
533. 
73. Wang, H. P., Schafer, F. Q., Goswami, P. C., Oberley, L. W., and Buettner, G. R. 
(2003) Phospholipid hydroperoxide glutathione peroxidase induces a delay in G(1) of 
the cell cycle, Free Radical Research 37, 621-630. 
74. Conour, J. E., Graham, W. V., and Gaskins, H. R. (2004) A combined in 
vitro/bioinformatic investigation of redox regulatory mechanisms governing cell 
cycle progression, Physiological Genomics 18, 196-205. 
75. Goswami, P. C., Sheren, J., Albee, L. D., Parsian, A., Sim, J. E., Ridnour, L. A., 
Higashikubo, R., Gius, D., Hunt, C. R., and Spitz, D. R. (2000) Cell cycle-coupled 
variation in topoisomerase II alpha mRNA is regulated by the 3 '-untranslated region - 
Possible role of redox-sensitive protein binding in mRNA accumulation, Journal of 
Biological Chemistry 275, 38384-38392. 
76. Atzori, L., Dypbukt, J. M., Sundqvist, K., Cotgreave, I., Edman, C. C., Moldeus, P., 
and Grafstrom, R. C. (1990) Growth-associated modifications of low-molecular 
weight thiols and protein sulfhydryls in human bronchial fibroblasts, Journal of 
Cellular Physiology 143, 165-171. 
77. Attene-Ramos, M. S., Kitiphongspattana, K., Ishii-Schrade, K., and Gaskins, H. R. 
(2005) Temporal changes of multiple redox couples from proliferation to growth 
arrest in IEC-6 intestinal epithelial cells, American Journal of Physiology-Cell 
Physiology 289, C1220-C1228. 
78. Hutter, D. E., Till, B. G., and Greene, J. J. (1997) Redox state changes in density-
dependent regulation of proliferation, Experimental Cell Research 232, 435-438. 
79. Sarsour, E. H., Kumar, M. G., Chaudhuri, L., Kalen, A. L., and Goswami, P. C. 
(2009) Redox Control of the Cell Cycle in Health and Disease, Antioxidiants & Redox 
Signaling 11, 2985-3011. 
80. Kosower, N. S., and Kosower, E. M. (1978) The glutathione status of cells, 
International Review of Cytology 54, 109-160. 
 21 
81. Filomeni, G., and Ciriolo, M. R. (2006) Redox control of apoptosis: An update, 
Antioxidants & Redox Signaling 8, 2187-2192. 
82. Orford, K., Orford, C. C., and Byers, S. W. (1999) Exogenous expression of beta-
catenin regulates contact inhibition, anchorage-independent growth, anoikis, and 
radiation-induced cell cycle arrest, The Journal of Cell Biology 146, 855-867. 
83. Ahmad, S., Okine, L., Le, B., Najarian, P., and Vistica, D. T. (1987) Elecation of 
Glutathione in Phenylalanine Mustar-Resistant Murine L1210 Leukemia-Cells, 
Journal of Biological Chemistry 262, 15048-15053. 
84. Midander, J., Deschavanne, P. J., Malaise, E. P., and Revesz, L. (1982) Survival 
curves of irradiated glutathione-deficient human-fibroblasts- indication of a reduced 
enhancement of radiosensitivity by oxygen and misonidazole, International Journal 
of Radiation Oncology Biology Physics 8, 443-446. 
85. Nguyen, L. N., Munshi, A., Hobbs, M. L., Story, M. D., and Meyn, R. D. (2001) 
Paclitaxel restores radiation-induced apoptosis in a bcl-2-expressing, radiation-
resistant lymphoma cell line, International Journal of Radiation Oncology Biology 
Physics 49, 1127-1132. 
86. Vukovic, V., Nicklee, T., and Hedley, D. W. (2000) Microregional heterogeneity of 
non-protein thiols in cervical carcinomas assessed by combined use of HPLC and 
fluorescence image analysis, Clinical Cancer Research 6, 1826-1832. 
87. Joncourt, F., Oberlischrammli, A. E., Stadler, M., Buser, K., Franscini, L., Fey, M. F., 
and Cerny, T. (1995) Patterns of drug-resistance parameters in adult leukemia, 
Leukemia & Lymphoma 17, 101-109. 
88. Perry, R. R., Mazetta, J., Levin, M., and Barranco, S. C. (1993) Glutathione levels 
and variability in breast-tumors and bormal tissue, Cancer 72, 783-787. 
89. Berger, S. J., Gosky, D., Zborowska, E., Willson, J. K. V., and Berger, N. A. (1994) 
Sensitive enzymatic cycling assay for glutathione- measurments of glutathione 
content and its modulation by buthionine sulfoximine in-vivo and in-vitro in human 
colon-cancer, Cancer Research 54, 4077-4083. 
90. Cook, J. A., Pass, H. I., Iype, S. N., Friedman, N., Degraff, W., Russo, A., and 
Mitchell, J. B. (1991) Cellular glutathione and thiol measurements from surgically 
resected human lung-tumor and normal lung-tissue, Cancer Research 51, 4287-4294. 
91. Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., 
and Weinberg, R. A. (1999) Creation of human tumour cells with defined genetic 
elements, Nature 400, 464-468. 
92. Hoffman, A., Spetner, L. M., and Burke, M. (2008) Ramifications of a redox switch 
within a normal cell: Its absence in a cancer cell, Free Radical Biology and Medicine 
45, 265-268. 
93. Havens, C. G., Ho, A., Yoshioka, N., and Dowdy, S. F. (2006) Regulation of late 
G(1)/S phase transition and APC(Cdh1) by reactive oxygen species, Molecular and 
Cellular Biology 26, 4701-4711. 
 22 
94. Limoli, C. L., Rola, R., Giedzinski, E., Mantha, S., Huang, T. T., and Fike, J. R. 
(2004) Cell-density-dependent regulation of neural precursor cell function, 
Proceedings of the National Academy of Sciences of the United States of America 
101, 16052-16057. 
95. Szatrowski, T. P., and Nathan, C. F. (1991) Production of large amounts of hydrogen-
peroxide by human tumor-cells, Cancer Research 51, 794-798. 
96. Brar, S. S., Corbin, Z., Kennedy, T. P., Hemendinger, R., Thornton, L., Bommarius, 
B., Arnold, R. S., Whorton, A. R., Sturrock, A. B., Huecksteadt, T. P., Quinn, M. T., 
Krenitsky, K., Ardie, K. G., Lambeth, J. D., and Hoidal, J. R. (2003) NOX5 
NAD(P)H oxidase regulates growth and apoptosis in DU 145 prostate cancer cells, 
American Journal of Physiology-Cell Physiology 285, C353-C369. 
97. Allen, R. G., and Balin, A. K. (2003) Effects of oxygen on the antioxidant responses 
of normal and transformed cells, Exp. Cell Res. 289, 307-316. 
98. Kim, K. J., Kim, M. A., and Jung, J. H. (2008) Antitumor and antioxidant activity of 
protocatechualdehyde produced from Streptomyces lincolnensis M-20, Archives of 
Pharmacal Research 31, 1572-1577. 
 
 23 
Chapter 3  
Electrochemical Platform for Cell Studies 
3.1 Introduction 
In this dissertation, the definition used for cellular redox state is “the balance between 
reactive oxygen species, ROS, and cellular antioxidants such as glutathione that scavenge 
them (1, 2).” Redox state can be determined by monitoring the glutathione/glutathione 
disulfide (GSH/GSSG) redox couple because of its abundance within cells (3). In fact, the 
progression of many biological processes depends upon the redox state of the environment in 
which the process takes place (4). Even within organelles, redox states vary in correlation to 
the function of the subcellular compartment (4). Also, as discussed previously, intracellular 
redox state is important in biological processes such as gene expression, differentiation, 
apoptosis, and cell cycle progression (5-7) and in biological “problems” such as 
tumorigenesis (8). Because of the importance of reduced and oxidized species in cellular 
processes, tools that adequately modulate and measure intracellular redox environment are 
desirable. To date, pharmacological methods have been largely used and, for the most part, 
are successful in modulating the intracellular redox environment of cultured cells (9, 10).  
Unfortunately pharmacological approaches often lack selectivity and frequently cause 
cellular toxicity (11, 12). Pharmacological methods also require significant manipulation of 
cell culture conditions which may perturb intracellular homeostasis. To overcome these 
problems, I report the use of a three-electrode electrochemical platform for modulating the 
intracellular redox environment of Chinese Hamster Ovary (CHO) cells in this Chapter. 
3.2 Materials and Methods 
Cell Culture. Chinese Hamster Ovarian (CHO) fibroblasts were obtained from American 
Type Culture Collection (Manassas, VA), and cultured in Dulbecco‟s modified Eagle‟s 
medium (DMEM), supplemented with glucose (25 mM), and dispensable amino acids (0.1 
mM) (GIBCO; Invitrogen, Grand Island, NY), sodium bicarbonate (44 mM), penicillin 
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(10,000 U/l) and streptomycin (10,000 U/ml), HEPES (15 mM), 10% fetal bovine serum 
(FBS), and Fungizone (250 μg/ml) in T-75 cell culture flasks (Costar, Cambridge, MA). 
Cells were incubated at 37°C in a humidified atmosphere of 5% CO2. Cell media was 
replaced approximately every three days. 
Working Electrode Preparation. Silicon wafers were coated with a 30 Å thick layer of 
titanium for adhesion followed by a 400 Å thick layer of gold using a Temescal FC1800 
electron beam deposition system (BOC Edwards, Inc., Livermore CA). After Ti/Au 
deposition the wafer was diced into 6 x 18 mm
2
 “chips” using a dicing saw (Disco 
Corporation, Manchester, NH).  These chips are referred to as Au-chips or Au electrodes in 
the text.  Indium tin oxide (ITO) working electrodes (18 x 18 mm
2
) were purchased from SPI 
Supplies ®; West Chester, PA. 
Cellular Growth and Attachment on Working Electrodes. Au chips were placed into 12 
well cell culture plates (Costar, Cambridge, MA), one chip per well. CHO cells were initially 
seeded at a density of 40,000 cells/Au chip (370 cells/mm
2
). Indium tin oxide substrates (SPI 
Supplies; West Chester, PA) were placed in 6 well cell culture plates (Costar, Cambridge, 
MA), one substrate per well. Cells were seeded at an initial density of 100,000 cells/ITO 
substrate (308 cells/mm
2
). Cells were allowed to attach for approximately 5 minutes. After 
which 2 ml of DMEM was added to each well and cells were allowed to grow for 2-3 days at 
culture conditions mentioned above. 
Effect of Electric Potential Application on Cell Viability. Substrates were removed from 
cell culture plates and washed with PBS. One by one, they were placed into the 
electrochemical platform filled with 3.5 ± 0.2 ml (first generation platform) or 4.5 ± 0.2 
(second generation platform) of PBS maintained at 37°C by a hot plate, and exposed to 
various electric potentials using a Potentiostat (Princeton Applied Research Corporation, 
Princeton, NJ) for 4 minutes. After potential application, cells were lifted from substrates 
using 0.5 ml of 1x trypsin/EDTA in HBSS followed by 0.9 ml of DMEM.  Cells were 
subsequently resuspended in 200 μl PBS and stained with 75 μl propidium iodide solution (1 
mg/ml, Sigma-Aldrich, Saint Louis, MO) for 5 minutes and kept on ice until analysis with 
flow cytometry.  
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Effect of Electric Potential Application on CHO Cell Redox State.  Substrates were 
removed from the cell culture plates, washed with PBS, and one by one placed into the 
electrochemical platform that was filled with PBS.  Cell were maintained at 37°C by a 
hotplate and exposed to various electric potentials using a Potentiostat for 4 minutes.  After 
potential application, cells were stained with 40 μM monochlorobimane (mBCl, Molecular 
Probes, Eugene, OR), a membrane-permeant probe that fluoresces in the UV spectrum upon 
reacting with free thiols (GSH most abundant) at 37°C for 5 minutes.  This reaction is 
catalyzed by the enzyme glutathione-S-transferase (15).  After washing with PBS cells were 
lifted from the chips using 0.5 ml of 1 x trypsin/EDTA in HBSS followed by 0.9 ml of 
DMEM.  Cells were subsequently resuspended in 300 μl of PBS followed by analysis with 
flow cytometry. 
Flow Cytometry.  Intracellular concentrations of GSH were determined by flow 
cytometry using a BD Biosciences LSR II flow cytometer (BD Biosciences, San Jose, CA).  
The fluorescence of monochlorobimane was quantified using a UV laser with an excitation 
wavelength of 405 nm. 10,000 events were analyzed per sample, dead cells were excluded 
from analysis by gating and viable cells were identified by their distinct forward-angle versus 
side-angle light scatter properties. Data were analyzed using FCS ® software (De Novo 
Software, Los Angeles, CA). 
GSH & GSSG Determination. [GSH] and [GSSG] were determined using high 
performance liquid chromatography and tandem mass spectrometry (LC/MSD Trap XCT 
Plus, Agilent Technologies; Massy, France). I used a previously described method (18) with 
modifications. CHO cells were exposed to either 0, -325 mV or +300 mV (n=6). Each data 
point represents the averages of 2 independent experiments. After potential application cells 
were prepared for HPLC-MS/MS analysis. Briefly, cells were washed twice with HBSS and 
lifted using 1x trypsin/EDTA. Cells were resuspended in 20 mM Ellman‟s reagent (Sigma-
Aldrich, Saint. Louis, MO).  Cells were lysed by 5 cycles of freeze-thaw method.  After lysis 
the suspension was centrifuged (13,000g, 5 minutes). The supernatant was used to quantify 
the concentrations of GSH, GSSG, cysteine, and cystine. Determination of the concentrations 
of analytes of interest was measured against an internal standard, GSHee. The reduction 
potential for the GSSG/2GSH couple was calculated using the Nernst equation at 37°C and 
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pH 7.2 [half-cell reduction potential, Ehc = –252 mV – (61.5/2)*log ([GSH]
2
/[GSSG])].  
Although cysteine could routine be measured, cystine measurements were on the order of the 
“noise” levels.    
Statistical Analysis. Comparisons between samples for determination of statistically 
significant differences were performed using the Microsoft Office Excel 2003 ® (Redmond, 
WA) Analysis of Variance (ANOVA) single factor data analysis tools. A p-value < 0.05 was 
considered significant for all statistical analyses performed. A minimum of three independent 
experiments with triplicate samples per treatment was performed per analysis. 
3.3 Results and Discussion 
3.3.1 First Generation Electrochemical Platform Design 
After a number of iterations, I developed a robust electrochemical platform for cellular 
studies. The platform is comprised of a working electrode (6 x 18 mm
2
 gold-covered silicon), 
two stainless steel counter electrodes arranged in a machined Teflon housing (Figure 3.1) 
and an external Ag/AgCl reference electrode connected via tubing. The platform also has a 
Teflon-bridge that enables the use of a pogo-pin for electrical contact with the working 
electrode. Using the bridge also ensures that working electrodes are completely submerged in 
the chamber, positioned flat on the bottom of the platform, and that seeded cells are covered 
by a uniform thickness of phosphate buffer solution (PBS). The entire system is maintained 
at 37°C by placing it on a hotplate. The 400 angstrom thick layer of gold as well as the 
placement and size of the counter electrodes in the side walls allows for homogeneous field 
distribution across the area of the working electrode, so all cells experience the same electric 
field. If homogeneous field distribution is not maintained within the electrochemical 
platform, fundamental analysis of the effects of extracellularly applied electric potential on 
cell populations becomes extremely difficult. I systematically resolved possible sources of 
non-homogeneous field distribution by ensuring that all electrical contacts between the 
Potentiostat and the electrodes were secure. The main chamber of the platform is also always 
filled with the same amount of PBS to ensure that consecutive chips are exposed to 
reproducible conditions. The external Ag/AgCl reference electrode allows for precise control 
of the absolute potential of the counter and working electrode, which is crucial in linking 
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biological events to certain cellular oxidation states. Another assessment of homogenous 
field distribution involves visual inspection of tubing that connects the reference electrode to 
the platform for air bubbles and by performing a platform pre-test. The platform pre-test 
consists of applying a potential to a chip that has no cells seeded on it. If air bubbles are 
present fluctuations will occur in the observed potential.  Bubbles are then removed.  If no air 
bubbles are in the system, the observed potential is consistent with the applied potential and 
experiments are started by replacing the chip without cells for these control experiments with 
a chip with a confluent layer of cells.  
Figure 3.1.  Three-electrode electrochemical platform comprised of two counter electrodes (stainless steel), a working 
electrode (6 x 18 mm2 Au on silicon substrate) in a Teflon housing.  The working electrode serves as the substrate for cell 
seeding and to apply an electric potential to cells after they reach confluence.  Electrical contact to the working electrode is 
made using a pogo pin. 
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For experiments, cells are seeded on the working electrode.  These cells are allowed to 
attach and grow to confluence.  The working electrode with a confluent layer of cells is then 
placed in the chamber and the cells are exposed to different electric potentials (-400 mV to 
+400 mV), typically for 4 minutes.  Previous time/dose response experiments, in which 
electric potentials were applied to cells seeded on Au surfaces followed by 
monochlorobimane staining to access relative fluorescence, revealed that 4 minutes was 
adequate and the optimum time for redox modulations. 
3.3.2 Cell Viability on Gold Substrates 
To ensure that applying electric potentials to CHO cells seeded on conductive substrates 
did not kill a significant number of cells or induce electropermeabilization, cell viability tests 
were conducted. Electropermeabilization, while useful in some areas of biomolecular 
research such as electrochemotherapy, is undesired here (13, 14). Electropermeabilization 
may lead to a loss of redox active species of interest such as GSH or GSSG through induced 
membrane pores, which would result in incorrect measurement of the intracellular redox 
state. In this viability experiment, cells were treated with electric potentials between -400 and 
+400 mV, heat treated at 65°C for 5 minutes (positive control), or untreated (0 mV, negative 
control). Cells were then stained with propidium iodide which only stains cells with a 
compromised cell membrane. Figure 3.2 shows representative frequency histograms 
indicating the number of live and dead cells after treatment. Cells with a compromised 
membrane (dead cells) exhibit a greater relative fluorescence than live cells. This data 
demonstrates that after applying a -400 or +400 mV potential to the cells the number of dead 
cells was not significant. Quantitative analysis reveals that typically > 90% of cells are viable 
after potential application. Cell death was not significant until cells were exposed to -1.2 V, a 
potential that is well outside of the range of interest as this potential is a non-physiological 
condition. Therefore, future observations of changes in intracellular redox state based upon 
applied extracellular electric potentials can be attributed to intracellular events rather than 
extracellular events such as induced membrane pores leading to cell death.     
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3.3.3 Intracellular GSH Response to Electric Potentials 
Next, I investigated the effect of applying extracellular electric potentials on the 
intracellular GSH. For example, a confluent layer of CHO cells (seeded on the working 
electrode) was exposed to negative potentials (0 to -325 mV) followed by another experiment 
in which the cells were exposed to positive potentials (0 to +400mV) (Figure 3.3). After 
cells were treated at these various electric potentials they were stained with a membrane-
permeable probe, monochlorobimane. Monochlorobimane fluoresces in the UV spectrum 
upon reacting with GSH or other free thiols. This reaction is catalyzed by the enzyme 
glutathione-S-transferase (15). After staining, cells were analyzed via flow cytometry.   
Figure 3.3 includes two frequency histograms for cells that were either reduced (Figure 
3.3a) or oxidized (Figure 3.3b) via the application of negative or positive electric potentials 
Figure 3.2.  Representative Frequency Histograms.  Live and dead populations of CHO cells are shown after treatment 
with (a) 0 mV (negative control); (b) +400 mV; (c) -400 mV; and (d) 65°C for 5 minutes (positive control).  Cells remain 
viable after extracellular electric potential application.  
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respectively.  Dashed vertical lines were added to assist with the visualization of peak shifts. 
Also, curves were offset on the y-axis by either 10 counts to improve visualization.   
Figure 3.3.  Representative Frequency Histograms.  Frequency histograms of cells 
treated at (a) control, 0 mV, -150 mV, -250 mV, and-325 mV (b) control, 0mV, +200 
mV, +300 mV, +400 mV for 4 minutes.  The histograms show that intracellular redox 
environment is modulated.  As the electric potential becomes more negative the 
GSH/GSSG balance shifts towards the reduced, GSH as more oxidizing (positive) 
potentials are applied to cells, the intracellular GSH/GSSG balance shits towards the 
oxidized, GSH.  Vertical dashed lines were added to assist with visualization of peak 
shifts. Curves were also offset on the y-axis by either 20 or 30 counts per unit for 
visualization purposes. 
 
(a) 
(b) 
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Analysis of representative frequency histograms revealed that the intracellular redox 
environment of CHO cells is modulated by applying extracellular electric potentials. As the 
applied electric potential becomes more negative the 2GSH/GSSG balance shifts towards the 
reduced form of this redox couple, GSH. Also as applied potentials become more positive 
(oxidizing) the amount of GSH decreases. Comparisons between samples for determination 
of statistically significant differences were performed using the Analysis of Variance 
(ANOVA) single factor data analysis tools (16). Statistical analysis revealed that the alpha 
value between all measurements was 2 x 10
-5
 (when reducing potentials were applied) and 9 
x 10
-4
 (when oxidizing potentials were applied), indicating statistical significance of the data 
(much smaller than the threshold of 0.05). These results validate the use of the 
electrochemical platform as a tool for modulating intracellular redox environment. These 
results in agreement with previously published literature that correlates more reduced cellular 
state to more positive electric potentials (4, 17).  
3.3.4 Intracellular Redox Potential 
Next, using an HPLC-MS/MS method (18), I attempted to measure the concentrations of 
GSH and GSSG, as well as cysteine and cystine followed by calculating the intracellular 
redox potential of CHO cells after exposure to extracellular electric potentials. In preliminary 
studies, cells were exposed to 0, -325 and +300 mV. Calculated intracellular redox potentials 
based upon the GSH/GSSG redox couple were -284 ± 16, -280 ± 11, and -263 ± 10 mV 
respectively. The expected trend for redox environment modulations indeed occurs when 
applying oxidizing potentials, however the error in the data is substantial. Also calculated 
redox potentials are higher than expected and reported in literature (4, 19). Further 
investigation revealed that measurements and resulting data obtained with the HPLC-MS/MS 
method often could not be trusted. Specifically, the GSSG concentrations were consistently 
outside of the expected range, thus yielding more reduced values for calculated redox 
potential. Also, the peaks measured for cystine were consistently in the range of “noise”, thus 
no reliable redox analysis could be done based on the cystine/cysteine redox couple. Other 
researchers have reported similar problems (18). During optimization of the HPLC-MS/MS 
protocols, I established that at least 4 million cells were needed per sample for sufficiently 
accurate and repeatable measurements of GSH and GSSG. This finding rendered this method 
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extremely time consuming because at least 20 working electrodes with confluent cell layers 
are needed to be treated for any single data point, with each sample taking about 20 minutes 
for potential application, and sample preparation for HPLC analysis preparation. In summary, 
the HPLC-MS/MS method is thus not advantageous over the method I described previously 
(Section 3.3.3), which involves analysis of cells exposed to different potentials via flow 
cytometry. However, both the HPLC-based and the flow cytometry-based method, which 
both involve the measurement of the intracellular redox state of bulk cell populations, were 
not exactly ideal to pursue our main research question of to what extent have tumor cells 
lost the ability to either mount or sense changes in intracellular redox potential as 
defined in Chapter 1. To overcome some of these problems we decided to modify our 
electrochemical platform, specifically so it would enable in situ analysis of individually cells 
using microscopy.  
3.3.5 Second Generation Electrochemical Platform 
The second generation electrochemical platform was also machined in Teflon (Figure 
3.4), but it was modified such that the cells could be observed in situ, while being exposed to 
different potentials. Like the first generation platform, this platform is comprised of a Teflon 
housing with two stainless steel counter electrodes embedded in the side walls, a reference 
electrode connected via tubing, and a working electrode placed between the two counter 
electrodes in the bottom of the chamber. In this second generation platform, the working 
electrode is an 18 x 18 mm
2
 transparent indium tin oxide (ITO) slide.   
Figure 3.4.  Three-electrode 
electrochemical Indium Tin Oxide based 
platform comprised of two counter 
electrodes (stainless steel), a working 
electrode (18 x 18 mm2 ITO substrate) in 
a Teflon housing.  The working electrode 
serves as the substrate for cell seeding 
and to apply an electric potential to cells 
after they reach confluence.  Electrical 
contact to the working electrode is made 
using a pogo pin. 
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ITO as the working electrode greatly enhances future research capabilities, because it will 
allow for less time consuming, in situ visualization of intracellular redox environment when 
combined with intracellular redox biosensor technology described in Chapter 5.  
Like before, I conducted a control experiment with respect to cell viability. Cells were 
seeded on ITO substrates and allowed to attach and grow to confluence after which cells 
were exposed to different potentials (Figure 3.5). Like cells seeded on Au in first generation 
devices, cells seeded on ITO substrates when exposed to various electric potentials remain 
alive (>90%). 
3.3.6 Intracellular GSH Response to Electric Potentials on ITO 
I also investigated the effect of applying extracellular electric potentials on the 
intracellular redox environment of cells seeded on ITO substrates.  For example, CHO cells 
were exposed to potentials between 0 and -400 mV (Figure 3.5).  As the applied electric 
potential becomes more negative the glutathione/glutathione disulfide (2/GSH/GSSG) 
Figure 3.5.  Representative Frequency Histograms.  
Live and dead populations of CHO cells are shown 
after treatment with (a) 0 mV (negative control); (b) 
+400 mV; (c) -300 mV; Cells remain viable after 
extracellular electric potential application. 
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balance shifts towards the reduced form of this redox couple, GSH, up to certain potentials.  
At some point, upon applying even more negative potentials (-400 mV), the cells seem to 
respond by becoming more stressed which leads to less GSH production and thus a shift in 
the opposite direction. Comparisons between samples for determination of statistically 
significant differences yielded a p-value of 6x10
-3
 (much smaller than the threshold of 0.05), 
so indeed these observed shifts are significant. For future experiments described in chapter 5, 
I hope to not only use this platform to reduce cells but to also oxidize cells. (Oxidation is 
more relevant to FRET-based biosensor studied). In summary, the results obtained with this 
second generation ITO-based platform show that these platforms can be used to modulate the 
intracellular redox environment of seeded cells. 
Figure 3.6.  Representative frequency histogram (flow cytometry) of CHO cells treated at 0 mV 
(black), -150 mV (red), -250 mV (blue), -325 mV (green), and -400 mV (purple) on ITO substrates 
for 4 minutes followed by staining with monochlorobimane. Histograms show that intracellular 
redox environment can be modulated by the second generation electrochemical platform. As the 
electric potential becomes more negative the GSH/GSSG balance slightly shifts towards the 
reduced, GSH up to certain potentials. 
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3.4 Conclusions 
Combining the electrochemical platform with the sensitivity of flow cytometry has 
enabled quick analysis of GSH and GSSG concentrations of large populations of cells.  A 
number of other studies have taken advantage of the power of flow cytometry to measure 
GSH concentration as well (15, 20).  This chapter demonstrates that the electrochemical 
platforms described can indeed be used to modulate the intracellular redox environment 
without harming cells.  As the applied electric potential becomes more reducing (negative) 
the 2GSH/GSSG balance shifts towards the reduced form, GSH, and as the applied electric 
potential becomes more oxidizing (positive) the amount of intracellular GSH decreases in 
favor of GSSG formation.  I hope to couple the power of our transparent, electrically 
conductive, indium tin oxide based platform with emerging efforts of real time monitoring of 
intracellular redox state, specifically intracellular redox-sensitive biosensors, see Chapter 5 
(21).  These tools for modulating and measuring intracellular redox environment will be 
useful for studying complex biological problems such as tumorigenesis and aiding in 
understanding the importance of redox in cellular processes such as density-dependent 
regulation, cell cycle progression and disease mechanisms. 
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Chapter 4  
Investigation of Isogenic Normal and Tumorigenic 
Porcine Cells for Redox Studies 
4.1 Introduction 
Cancer, one of the most devastating diseases of our time, causes about 13% of all deaths. 
According to the American Cancer Society, 7.6 million people died from cancer in the world 
during 2007. This rate is second only to heart disease and is quickly increasing (American 
cancer society, 2007). Because of this worldwide epidemic of cancer cases, a need to 
understand the basic mechanism involved in the onset and progression of this disease exists. 
Tumorigenesis in humans is a multistep process that involves progressive genetic 
transformations (3). Hanahan et al. suggest that no matter the cancer type, there are six 
characteristic perturbations that may occur which include proliferation without expression of 
growth signals, insensitivity to anti-growth signals, avoidance of apoptosis, limitless 
potential to replicate, sustained angiogenesis, and tissue invasion and metastasis (Figure 
Figure 4.1. Acquired capabilities of cancer.  Model 
suggest by Hanahan et al. highlighting the “functional 
capabilities” that cancer cells acquire during 
development and progression which include: 
proliferation in the absence of normal growth signals, 
insensitivity to anti-growth signals, evasion of 
apoptosis, limitless replicative potential, sustained 
angiogenesis and tissue invasion and metastasis (3).  
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4.1). Genetic transformations that accompany these processes include inactivation or lower 
expression of tumor suppressor genes, oncogene activation, and over-expression of 
angiogenic factors (4). 
As discussed in Chapter 2, in normal cells, growth and division is highly ordered 
encompassing tightly regulated biochemical and genetic pathways, loss of which can lead to 
abnormal proliferation (5). As normal cells progress through the cell cycle, their intracellular 
redox environment modulates (6, 7). Redox modulations, as observed by the status of the 
GSH/GSSG redox couple, accompany major transitions of the cell cycle such as 
proliferation, differentiation, senescence and death (5, 8-10). Controlled regulation observed 
in normal cells is lost in tumorigenic cells (11). Although the role of redox regulation in the 
mechanisms of cancer is an interesting and important topic, further investigations are needed 
to unravel the exact role of redox regulation in determining cell fate. The key question still 
remains: to what extent have tumor cells lost the ability to either mount or sense changes 
in intracellular redox potential?   
To further investigate this question, I used novel 161 porcine cells obtained from 
collaborator, Professor Counter, Duke University, (Durham, NC) (4). The main advantages 
of using these porcine cells are that parallels in cancer biology between humans and pigs are 
conserved even at the molecular level and these cells are genetically isogenic (4). Thus 
comparisons and correlations made between derived cell lines can be directly inferred with a 
greater level of confidence than using non-isogenic cell lines. 
4.2 Model 161 Porcine Cells 
4.2.1 Genetically Isogenic 161 Porcine Cell Development 
161 porcine fibroblasts were obtained from an ear notch biopsy of a healthy 
Yorkshire/Duroc female embryonic pig. Fibroblasts were chosen because they are easily 
isolated, culture conditions for fibroblasts are well established, and human fibroblasts can 
also be converted to tumorigenic state by inactivation of the protein 53 (p53), retinoblastoma 
protein (Rb) pathways by expression of dominant-negative, p53
DD
, and an activated cyclin-
dependent kinase (CDK)/cyclin complex (cyclin D1/CDK4
R24C
) in conjunction with 
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activation of c-Myc, Ras and human telomerase reverse transcriptase (hTERT) pathways (12, 
13) via expression of oncogenic forms of c-Myc (c-Myc
T58A
) and H-Ras (H-Ras
G12V
) and 
hTERT. Early passage porcine cells were sequentially and rapidly infected over the course of 
six days with retroviruses encoding transgenes, hTERT and p53
DD
, cyclin D1/CDK4
R24C
, and 
c-MyC
T58A
 and H-Ras
G12V
. The resulting polyclonal populations were confirmed by reverse 
transcriptase-polymerase chain reaction (RT-PCR) to express the desired combinations of 
transgenes. 
For my studies, seven cell lines were available which include 161 control (161C), 
expressing no transgenes, 161T (6 gene) (161T), expressing all six transgenes, and five other 
cell lines 161T-hTERT, 161T-p53 (161T+p53), 161T-cyclin, 161T-CDK, and 161T-Ras that 
lack the one indicated transgene.   
4.2.2 Tumor Suppressors and Oncogenes in Tumorigenesis 
As discussed previously cell lines were created by inactivation of tumor suppressor 
genes, activation of cyclin/cyclin dependent kinase cell cycle regulators, and via perturbation 
of the regulatory mechanisms of proto-oncogenes, all of which have an influence on the 
onset, progression and invasiveness of tumorigenic cells. Signaling pathways that are 
abnormally activated in human cancer can interfere with normal proliferation as well as 
support cell survival, even under adverse conditions such as low nutrient or oxygen levels 
(4).   
Below I will briefly describe the above mentioned tumor suppressor proteins or proto-
oncogenes and their cellular products and their affect on molecular pathways. I will also 
highlight the implication of these tumor suppressors and proto-oncogenes in various types of 
cancer.  Most pathways have been adopted from complex pathways (KEGG PATHWAY); 
yet simplified as much as possible for the purposes of this dissertation. 
HRAS: The human gene HRAS, first identified in Harvey rat sarcoma, encodes the protein, 
H-Ras and is involved in regulating cell growth in response to extracellular growth factor 
stimulation (1). The H-Ras protein is a GTPase, an enzyme responsible for the hydrolysis of 
guanosine triphosphate (GTP), and is an early player in a number of pathways including the 
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mitogen-activated protein kinase/ extracellular signal-regulated kinase (MAP/ERK) pathway 
(14,16) (Figure 4.2). The H-Ras protein binds to guanosine triphosphate (GTP) in the active 
state and cleaves the terminal phosphate of this nucleotide converting it to guanosine 
diphosphate (GDP). Upon conversion of GTP to GDP, in normal, non-transformed cells, H-
Ras is turned off (15). However, activated H-Ras initiates a cascade of events associated with 
the cell division. H-Ras activates serine/threonine enzyme (Raf). Phosphorylation of Raf 
activates mitogen-activated protein kinase kinase, which in turn is phosphorylated and 
activates mitogen activated protein kinase (1). Overactive H-Ras promotes cell proliferation 
in the absence of growth signals such as diffusible growth factors and extracellular matrix 
component, leading to uncontrolled cell division and tumor formation (3). About 30% of all 
tumors are activated by a mutation in RAS genes (17). Ras is mutated in 15-20% of lung 
cancer and 30-50% of adenocarcinomas (18). 
The H-Ras protein has been implicated both as an initiator of oxidant linked signaling 
and a target for oxidative regulation (19). These oxidative signals may be transmitted to 
extracellular signal-regulated kinase (ERK) pathway through H-Ras (20-22). H-Ras has a 
region of four reactive cysteines that are subject to oxidative modifications that may alter its 
cellular function (23). This finding may be important in understanding the link between H-
Ras and redox regulation in tumor cell proliferation. 
Figure 4.2.  Schematic of the H-Ras and the MAP/ERK pathway. In many cell types, activation of this pathway 
promotes cell division. Activated H-Ras activates serine/threonine-protein (Raf) kinase. Raf kinase phosphorylates 
and activates mitogen-activated protein kinase kinase (MEK). Phosphorylated  MEK activates a mitogen-activated 
protein kinase (MAPK/ERK) (1). 
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MYC (c-Myc): Vennstrom et al., discovered the cellular homolog, proto-oncogene MYC (c-
Myc), of viral myc (v-myc) (24). Myc functions as an oncogenic transcription factor 
promoting proliferation (25, 26) as well as initiating apoptosis via the downregulation of  B-
cell lymphoma 2 (Bcl-2)  (27). The MAPK/ERK pathway activates MYC (28) (Figure 4.3). 
Activated c-Myc also plays a role in other cellular pathways such as p53 where it activates 
alternate reading frame (Arf) nuclear tumor suppressor, which activates p53 indirectly (2). 
 
human telomerase reverse transcriptase (hTERT): hTERT is the catalytic ribonucleoprotein 
component of human telomerase whose function is to synthesize the repetitive nucleotide 
sequence (TTAGGG in humans) forming the telomeres at the end of chromosomes (29). 
When some telomerases are permanently activated cells and their offspring acquire limitless 
replicative potential (12). Telomerase activation has been observed in approximately 90% of 
all human tumors, highlighting its role in tumor progression, thus making it a target for 
cancer gene therapy (30). Human telomerase reverse transcriptase is strongly associated with 
c-Myc, an activator of hTERT, which is over-expression in prostate cancer and it appears to 
be down-regulated by p53 (31). 
Figure 4.3.   Activation of c-Myc. c-Myc is activated via the MAP/ERK pathway and interacts with the 
previously discussed H-Ras. The additional steps include phosphorylation of mitogen and stress activated protein 
kinase 1 (MSK1) followed by indirect (undetermined) interaction with DNA. Activation of c-Myc activates the 
cyclin D 1cylcin dependent kinase cyclin D1/CDK4 complex.  [Adopted from KEGG Pathway (2)]  
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Cyclin D1 and cyclin dependent kinase (cyclin D1 & CDK4): cyclin D1 is the protein 
encoded by the CCND1 gene which functions as a regulatory subunit for cyclin dependent 
kinases such as CDK4 and CDK6.  The activity of cyclin D1 is required for cell cycle gap 1/ 
synthesis phase (G1/S) transitions, thus affecting virtually all cells (32, 33). Cyclin dependent 
kinases/cyclin D1 complexes promote cell cycle progression by phosphorylating and 
inactivating the retinoblastoma (Rb) protein (34). Cyclin/CDK complexes are also involved 
in the downstream signaling of the p53, H-Ras and c-Myc pathways. Mutations and over 
expression of cyclin D1 have been linked to development, progression and onset of breast, 
bladder and lung cancer (35-38) .   
Exposure to H2O2 also causes cyclin D1 activation and accumulation in certain types of 
fibroblasts exhibited by increase in the GSSG:GSH ratio and inhibition of cyclin D1 
degradation (39). Also, redox regulation of cyclin D1 may be associated with changes in the 
redox state of critical cysteines within its structure, which cause conformational changes and 
effect phosphorylation (5). 
Protein 53 (p53): The gene TP53 codes for the p53 protein.  Protein 53 is described as a key 
cell cycle regulator and it is well studied (40-44). Protein 53 is activated during cellular stress 
such as exposure to carcinogens, UV, γ, and X irradiation (Figure 4.4). 
More than 50% of human cancers contain a mutation or deletion of the TP53 gene (48). 
In fact, TP53 has been indicated as the most commonly mutated gene in breast and colon 
cancer (49). In breast cancer p53 mutation is linked to more aggressive disease and worse 
overall survival rates (50). 
The redox active domain of p53 is characterized by three cysteines which can be 
irreversibly oxidized. Its oxidized form cannot bind to DNA, thus, limiting its ability to 
function as a tumor suppressor (51). 
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Summary 
Each of the above mentioned cell cycle regulators, oncogenes and tumor suppressors are 
important in tumorigenesis, many of which are interconnected and related to abnormal 
proliferation. Mutations in more than one of these genes are typically needed for robustly 
transformed tumor propagation in porcine and human cells (12, 13). For example, deletion of 
just one of the transgenes often yielded cells that do not grow in soft agar (unable to support 
anchorage-independent growth), a common characteristic of cancer cells and would not 
produce tumors in vivo when injected into immune-compromised mice (13,4); highlighting 
the complexity of cellular defense mechanisms.  The results and discussion section will 
highlight results from investigations of the model 161 porcine cells, previously not available.  
To further simplify studies mostly 161C, 161 T and 161 T+p53 cells were used. 
4.3 Materials and Methods 
Cell Culture. The 161 porcine cells were obtained from Professor Counter, Duke 
University, (Durham, NC) (4) and maintained in DMEM/F-10 media supplemented with 
glucose (25 mm), and dispensable amino acids (each 0.1 mM), sodium bicarbonate (44 mM), 
Penicillin (40,000 U/l) and Streptomycin (40,000 µg/l), HEPES (15 mM), 10% FBS 
(tumorigenic cell lines) and 15% FBS (161 control cells), Funigizone (250 µg/ml), and 
Figure 4.4.   Schematic of p53 pathway.  Cellular stresses such as irradiation produce DNA strand breaks that 
result in accumulation and activation of p53. Activation of p53 results in the transcriptional transactivation of 
many genes such as the murinedouble minute 2 (MDM2), cyclin-dependent kinase inhibitor 1A (p21), and 
insulin-like growth factor (IGF).  Cellular response is either cell growth arrest or apoptosis, depending upon 
the extent of DNA damage and the level of p53 present  
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Insulin (0.1 U/ml).  Cells were incubated at 37°C in a humidified atmosphere of 5% CO2 and 
serially passaged in 75-cm
2
 tissue culture flasks
 
(Corning, Corning, NY).  For all 
experiments, cells were used between passages 7 and 15.  
Growth Curve. 161 porcine cells were seeded at an initial densities of 2 x 10
4
 
(tumorigenic cells) and 5 x 10
4
 (control cells) cells per
 
well (12-well plates; Corning), 
cultured, and harvested every other day for up
 
to 12 days.  Cell media was changed every 
day. After harvesting, cells were stained with Trypan
 
blue, and live cells were counted with a 
hemocytometer. 
GSH Content of 161 Porcine Cells.  161 pig cells were seeded in 12-well cell culture 
plates (Costar, Cambridge, MA) (N=4) and allowed to grow for 5 days.  Each tumorigenic 
cell line was seeded at an initial density of 2 x 10
4
 cells/well and the 161 control cells were 
seeded at an initial density of 5 x 10
4
 cells/well.  After harvesting analyzed via HPLC-
MS/MS previously described.  Milligrams of protein was determined using a BCA
TM
 protein 
assay kit (Thermo Scientific; Waltham, MA). 
Cell volume. Cell volume was estimated via a Multiphoton Confocal Microscope (Zeiss 
Inc.; Bethel, CT) method previously described (52-54) with a few modifications.  Cells were 
stained with CMFDA-cell tracker green cytoplasmic stain (Invitrogen; Carlsbad, CA), a 
membrane permeable thiol active die, for 15 minutes followed by Hoechst (Invitrogen; 
Carlsbad, CA), a membrane permeable nuclear stain.  Cell volumes were used to calculate 
metabolite concentrations (e.g. GSH and GSSG). Cell volume was determined using a 
computer software, Imaris (Bitplane; Saint Paul, MN). 
GSH & GSSG determination. [GSH] and [GSSG] were determined using a method 
previously described (55) with modifications.  Briefly, cells were washed twice with HBSS 
and lifted using 1x trypsin.  4 million cells were used per sample.  Cells were pelleted via 
centrifugation (5,000g, 2 minutes) and resuspended in 20 mM Ellman‟s reagent.  Cells were 
lysed by 5 cycles of freeze-thaw method.  After lysis the suspension was centrifuged 
(13,000g, 5 minutes).  The supernatant was used to quantify [GSH], [GSSG], cysteine, and 
cystine.  Although cysteine could routinely be measured, cystine measurements were on the 
order of the “noise” levels.  Determination of the levels of analytes of interest was measured 
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against an internal standard, GSHee.  The reduction potential for the GSSG/2GSH couple 
was calculated using the Nernst equation at 37°C and pH 7.2; (Ehc) = -252 mV- (61.5/2)*log 
([GSH] 2 / [GSSG])] (56). 
Statistical Analysis.  Comparisons between samples for determination of statistically 
significant differences were performed using the Student‟s t test (57).  A p-value < 0.05 was 
considered significant for all statistical analyses performed.  A minimum of three 
independent experiments with triplicate samples per treatment were performed per analysis. 
4.4 Results and Discussion 
4.4.1 Morphology and Growth 
First 161 porcine cells were characterized based upon their morphology, growth rate and 
doubling time from growth through 12 days of culture.  To analyze the growth properties of 
161 porcine cells, each cell line was seeded and allowed to grow in 24-well cell culture plates 
for 10 days.  Bright field images were obtained daily (Figure 4.5). 
161C cells appear more fibroblast shaped (elongated) while 161T cells appear more 
rounded. The characteristic roundedness of 161T cells is also seen in other tumorigenic 
porcine cell lines with the exception of 161T-Ras cells, which are more similar in shape to 
161C cells. Tumorigenic cell lines also tended to grow in clumps after no less than 80% 
confluence with the exception of 161T-cyclin cells that grow in clumps from 2 days after 
growth and never reach confluence. Also, tumorigenic cells were loosely adherent to cell 
culture flasks, while control cells were extremely adherent and often times difficult to 
dislodge from cell culture flasks. 
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4.4.2 Cell Volume Measurements 
To determine the concentrations of intracellular analytes of interest, the volume of 161 
porcine cells was measured using confocal microscopy (52-54). Fluorescent images of cells 
stained with membrane permeable nuclear and cytoplasmic probes were captured and 
overlaid with a brightfield image (Figure 4.6).  Using Imaris
R
 computer software, 3 
dimensional contour images were created and volumes determined.  Contour images allowed 
for the calculation of the cytoplasmic and nuclear volumes. 
The total volume was determined by summation of nuclear and cytoplasmic volumes.  The 
calculated volume for 161C, 161T and 161T+p53 cells was 11.75 ± 3, 4.5 ± 1.4, and 3.75 ± 1 
100 microns 
Figure 4.5.   Brightfield micrographs of isogenic porcine cells. This image 
highlights phenotypic growth related differences. Normal non-transformed 
control cells (161C) differ in morphology from and 161 tumorigenic cell 
lines. Control cells are more fibroblast shaped (elongated) while 
tumorigenic cells are more rounded. 161C cells exhibit contact inhibition 
tumorigenic cells do not. (x 20). (With Fang Yang) 
 
 
161C 161T 161T+p53 
161T-hTERT 161T-CDK 161T-cyclin 
100 microns 
161T-Ras 
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respectively.  The nuclear volume to total volume ratio was found to be on the order of 10% 
for 161C cells and 20% for tumorigenic cells.  The volume of 161 control cells is about 3 
times greater than that of tumorigenic cells.  
4.4.3 Growth Rate of 161 Porcine Cells 
161 porcine cells were also characterized based upon their growth rate and doubling time 
from seeding through 12 days of culture. To analyze the growth properties of porcine cells, 
each cell line was seeded and allowed to grow in 24-well cell culture plates for 12 days. 
Every other day cells were harvested and counted to determine the doubling time of each cell 
line (Figure 4.7).  The doubling times of 161C, 161T, 161T+p53, 161T-hTERT, 161T-CDK, 
161T-cyclin, and 161T-Ras was determined to be 68, 33, 32, 31, 34, 58, and 39 hours 
respectively.  As expected, tumorigenic cells are more proliferative than normal, non 
Figure 4.6.  Cells in preparation for volume determination. Overlaid fluorescent and brightfield images of (a) & (d) 
161C; (b) & (e) 161T; and (c) & (f) 161T+p53 in 2D and 3D space. Control cells are more fibroblast shaped while 
tumorigenic cells are more rounded.  The total volume of control cells is about 3 times greater than that of 
tumorigenic cells. (x 40) (With Dr. Sivaguru & Adam Farag)  
 
 
 
100 microns 
(a)
(d)
(b) (c)
(e) (f)
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tumorigenic cells.  Also, the growth rates of all tumorigenic cell lines are not significantly 
different from each other.  
4.4.4 GSH Content of 161 Porcine Cells 
Next, I conducted an experiment to determine the amount of GSH in porcine cells and to 
further develop the HPLC-MS/MS protocol specifically for these cells. Porcine cells were 
seeded and grown for 5 days.  After 5 days of growth they were harvested and prepared for 
HPLC-MS/MS analysis.  The concentration of GSH per milligram of protein is reported here 
(Figure 4.8).  GSH concentrations of 161C and 161T were significantly different from each 
other while concentrations of the other available cell lines were not significantly different 
from the control. 
While developing the HPLC-MS/MS method for 161 porcine cells, I established that like 
CHO (Chapter 3) cells, at least 4 million cells are necessary for accurate and reproducible 
data. Also, although helpful, calculating the milligrams of protein per sample was another 
procedural step that could be eliminated by determining actual rather than estimated volume 
cell volume. 
Figure 4.7. Growth curve for isogenic 161 porcine cells. Cells were culture for 12 days and counted every other 
day to determine their doubling time. Tumorigenic cells grow faster than (more proliferative) than 161C cells. 
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4.4.5 Density Dependent and Redox Measurements 
In vivo redox potentials were measured in culture for normal fibroblasts, 161C, at 
varying densities including: sparsely seeded (approximately 35-40% confluent) and densely 
seeded (100% confluent) cells. Redox determinations, shown in Figure 4.9, revealed that the 
redox potential of sparsely seeded 161C cells was -215 ± 0.2 mV while that of contact 
inhibited, densely seeded, cells was -171 ± 0.5 mV. For comparisons, the redox potential of 
161T and 161T+p53 cells, which do not exhibit contact inhibition, was determined for both 
sparsely and densely seeded populations. The redox potential of 161T sparsely and densely 
seeded cells was d to be –243 ± 5 mV and -209 ± 2 mV respectively while the redox 
potential of 161T+p53 sparsely and densely seeded cells was -240 ± 2 mV and -217 ± 6 mV. 
Data is a composite of data from three independent experiments. Sparsely seeded cells, 
whether tumorigenic or normal, were always more reduced than their densely seeded 
counterparts (p-values 161C, 0.007; 161T, 0.002; and 161T+p53, 0.01).  This suggests that 
cells that are actively proliferating are more reduced than contact inhibited or cells that are 
crowded (tumorigenic cells). Also, upon comparing control verses tumorigenic cells, 
Figure 4.8.   GSH content (nmol/mg protein) of 161 porcine cell lines.  The GSH concentration of 161T 
is greater than that of other cell lines. The p-value, 0.009, indicates statistical significance. Concentration 
of other tumorigenic cell lines was comparable to 161C cells.  
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tumorigenic cells, whether sparsely or densely seeded, were always more reduced than 
control, non-transformed cells, demonstrating that tumorigenic cells are more proliferative. 
Statistical analysis (p-values of 9.3 x 10
-4
, and 0.002 for sparsely and densely seeded 161C 
verses 161 tumorigenic cells respectively) confirms that calculated redox potentials of 
sparsely and densely seeded 161C cells are statistically significant from both tumorigenic 
cells lines.  
I have also included a table below which highlights the measured concentrations of 
GSH/GSSG used to calculate redox potentials. Concentrations of the cysteine/cystine redox 
couple and redox potentials calculated based upon this redox couple are also included. Again 
data represent a composite of three independent experiments.  Calculated redox potentials for 
the cysteine/cystine redox couple are not statistically different. 
Figure 4.9. The effect of culture density on redox state.  Non-transformed, 161C cells, 161T and 
161T+p53 cells were grown in T-75 cell culture flasks and allowed to grow until desired confluence was 
reached. Dotted bars represent sparsely seeded cells and striped bars represent densely seeded cells.  
Values obtained are averages of three independent experiments. Redox potentials were calculated using 
the GSH/GSSG redox couple.  The p-values 9.3 x 10-4 and 0.002 indicates that redox potentials of 161C 
cells are statistically different from tumorigenic cells whether sparsely or densely seeded respectively.  
Redox potentials for tumorigenic cells; however, are not statistically different from each other.  
100 micron 
 Sparsely: p=9 x10-4 
Densely: p=0.002  
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4.5 Conclusions 
My studies, characterizing novel 161 porcine cells show that normal (161C) and 
tumorigenic cells (161T, 161T+p53) differ in morphology, growth rate, level of GSH, and 
intracellular redox potential.  Cancerous cells are more reduced than normal cells. This is 
consistent with literature (58). Sparsely seeded, growing, 161C are more reduced than 
confluent 161 control cells. Calculated redox potentials suggest that confluent porcine cells 
may exhibit some type of trigger dependent redox modulations that result in cessation of 
growth as outlined in Chapter 2 (56). 
Model 161 cells will greatly enhance understanding of the differences between 
transformed and non-transformed cells. 161C and 161T cells appear to best suited for these 
comparisons. Chapter 5 will highlight work performed by collaborators using porcine cells 
transfected with FRET-based biosensors (59).  
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Chapter 5 
Validation of FRET-based Biosensors 
5.1 Introduction 
As mentioned in previous chapters traditional tools for both modulating and measuring 
intracellular redox environment have their limitations. Conventional methods for measuring 
the status of important redox couples lack well-defined specificity, disrupt cellular integrity, 
and/or modulate cellular homeostasis (2). For example, some redox-sensitive fluorescent 
dyes that are often used to measure oxidized species within cells interact with oxidants and 
may cause artificial ROS formation (3). Also, customary redox measurements of glutathione 
and cysteine, for example HPLC, though specific for the respective redox couples, require 
cell lysis and analytical separation procedures that add to the complexity, thus, making 
measurements susceptible to artifacts (2, 4). As I illustrated in Chapters 3 and 4, to some 
extent, my own research was limited by conventional methods. To overcome these problems, 
genetically encoded biosensors have been created which use a variety of redox-sensitive 
fluorescent proteins (1, 5-8). In this Chapter, I highlight some of the successes that I, and 
mostly my collaborators, Dr. Vladimir Kolossov, Dr. Gene Tsvid, and Dr. Chunchen Lin 
achieved using cells transfected with FRET-based biosensors developed by Dr. Kolossov that 
enable real-time and extended measurement of modulations in intracellular redox without 
cellular disruption (1).  Use of the second generation electrochemical platform that I 
described in chapter 3 in combination with these redox biosensors has tremendous potential 
in trying to unravel the role of redox regulation in cell cycle events, including un-inhibited 
proliferation (cancer). 
FRET-based Biosensors 
Förster resonance energy transfer (FRET) is an optical technique based upon the transfer 
of excited state energy from a fluorescent donor molecule to an acceptor molecule by long-
range resonance coupling between the donor and acceptor (9). The orientation and distance 
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Figure 5.1. Schematic of redox sensitive switching 
mechanism for a single molecule. In the reduced 
state, distance between the donor and acceptor 
decreases the probability of FRET response 
between the donor and acceptor. In the oxidized 
state the donor and acceptor are closer, therefore, 
FRET response is more probable. The extent of 
energy transfer is quantified from the increased 
emission of the acceptor [Adopted from (1)].  
 
(typically 1-10 nm) between the donor and acceptor determine the efficiency of energy 
transfer (9). In the FRET-based biosensor, redox modulations induce a molecular 
conformational change in the redox senor which alters the distance between the FRET 
donor/acceptor pair (Figure 5.1). This conformational change causes a detectable change in 
the FRET efficiency as measured by changes in emission spectra profiles (1). Dr. Kolossov 
has used the emerging technologies of redox polypeptide switches (10, 11) and helical linkers 
(12, 13) to develop chimeric peptides that serve as redox-sensitive linkers between donor and 
acceptor molecules. The linkers between the donor and acceptor molecules consist of α-
helical structures in conjunction with different types of redox switches (1). The FRET-
construct that was used in this Chapter is CY-RL7 which includes GFP variants cyan (donor) 
and yellow (acceptor) and redox-sensitive linker 7 (RL7), (predicted to be 67.5 Å including 
four vicinal cysteines rationally embedded into the α-helical structure).  
 
Dr. Kolossov previously showed in vitro that FRET-based biosensors are sensitive to 
redox changes and that biosensor conformational changes are reversible. Also, for these 
studies, an important assumption is that biosensors interact with and are specifically 
responsive to the GSH/GSSG redox couple. For various experiments aimed at validating 
biosensors in vivo Dr. Kolossov modulated the intracellular redox environment via redox 
active chemicals such as L-buthionine-SR-sulfoximine (BSO), diazene dicarboxylic acid bis 
5 N, N-dimethylamide (diamide), 1, 3-bis [2-chloroethyl]-2-nitrozourea (BCNU), 1-chloro-
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2,4-dinitrobenzene (CDNB) and dithiothreitol (DTT) which all have their own mechanism of 
reactivity. Figure 5.2 highlights glutathione homeostasis and the way in which where various 
chemical inhibitors interact with GSH/GSSG production mechanics. 
L-buthionine-SR-sulfoximine (BSO) is a transition state inactivator of glutamate cystine ligase 
(GCL) that catalyzes the first limiting step of GSH synthesis. BSO and related sulfoximines 
are highly selective inactivators (14, 15). BSO does not react with GSH and there is no 
evidence that the sulfoximine moiety exerts toxicity at most concentrations used in 
experiments; thus, effects observed after treatment with BSO, which may be ascribed to GSH 
deficiency, are produced by the reactive species that are formed in normal metabolism (16). 
Diazene dicarboxylic acid bis 5 N, N-dimethylamide (diamide) is a non-specific agent that 
promotes reversible oxidation of glutathione and other protein thiols to their disulfide forms 
(17, 18). 
1, 3-bis [2-chloroethyl]-2-nitrozourea (BCNU) is an antitumor drug commonly known as 
Carmustine (19, 20). Upon decomposition in situ, BCNU inhibits cellular glutathione 
reductase (GR), which results in depletion of GSH and accumulation of GSSG (21, 22). 
CDNB, which stands for 1-chloro-2,4-dinitrobenzene, is an electrophilic, xenobiotic agent 
that is detoxified via conjugation to GSH, resulting in rapid and complete depletion of the 
cellular GSH pool (23). 
DTT, which stands for dithiothreitol , is a protective agent for SH groups, used as a reducing 
agent for proteins and enzymes and an enhancer of DNA polymerase activity (24). 
5.2 Materials and Methods   
Cell Culture. CHO cells were cultured in Dulbecco‟s modified Eagle‟s medium 
(DMEM), supplemented with glucose (25 mM), and dispensable amino acids (0.1 mM) 
(GIBCO; Invitrogen, Grand Island, NY), sodium bicarbonate (44 mM), penicillin (10,000 
U/l) and streptomycin (10,000 U/ml), HEPES (15 mM), 10% fetal bovine serum (FBS) and 
Fungizone (250 μg/ml) in T-75 cell culture flasks (Costar, Cambridge, MA). Cells were 
incubated at 37°C in a humidified atmosphere of 5% CO2. 161C cells were cultured in 
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(DMEM/F-10) as described above yet with 15% FBS. 161T and 161T+p53 were cultured in 
(DMEM/F-10) with 10% FBS. Cells transfected with the Fret-biosensors were cultured in 
presence of G418 (15 µl/ml). 
Genetic Constructs. The redox-sensitive linker, RL7 and the polyproline linker P14 were 
designed as described earlier (1). Constructs CY-RL7 and CY-P14 were built by the insertion 
of linkers between ECFP/EYFP pair cloned into mammalian vector pECFP-C. 
Transfection. Transfection solutions were prepared in accordance to Nucleofector Kit ® 
specifications (Lonza; Walkersville, MD). The transfection solution was mixed with DNA 
(typically 0.3 µg/µl). One millions cells were always used per transfection. Transfection was 
performed using a Nucleofector ® (Lonza; Walkersville, MD). One day after transfection, G-
418 sulfate antibiotic (SIGMA-ALDRICH; St. Louis, MO) was added to cell culture media. 
Cell sorting. 161T cells were sorted using a MoFlo
TM
 (DakoCytomation; Ft. Collins, CO) 
high-performance cell sorter mounted on a single 72 ft
2
 optical table using 488 nm laser.  
Cells were sorted into 6-well cell culture plates (Costar, Cambridge, MA), 20 cells per well. 
Cells were sorted into three populations based upon fluorescent intensity, R4 (lowest level), 
R5 (intermediate level), and R6 (highest level) and allowed to grow. 
Flow cytometry. Cells were pretreated with 1 mM DTT (SIGMA-ALDRICH; St. Louis, 
MO), 1 mM CDNB (SIGMA-ALDRICH; St. Louis, MO) or 1 mM diamide (SIGMA-
ALDRICH; St. Louis, MO) for 5 minutes followed by flow cytometry analysis.  The FRET 
channel was normalized over YFP to account for variations in fluorescence intensity among 
different experiments. The bar graph represents the geometric mean of each histogram 
averaged over four cell counting histograms from two experiments ± SD. 
Microscopy.  Cells were imaged on a Zeiss Axio-Observer inverted microscope with a 
Zeiss Achroplan 100x oil immersion objective (1.3NA). The microscope is equipped with 
environmental chamber that is temperature controlled to 37°C during live cell imaging. In 
addition, μ-slide (Ibidi, Germany) was placed inside a closed microincubator 
(BioscienceTools, TC-MI) for more accurate CO2 control. A Pecon CO2 controller controls 
5% CO2 content as measured inside the controller and not at the slide location. Images were 
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taken with 1024 x 1024 EMCCD camera (Andor, DU-888) operated at -70°C. The inverted 
microscope has a three-filter cube system for FRET assay (25). A three-filter cube system 
eliminates the cross-talk between donor and acceptor fluorescence with carefully selected 
fluorophore pairs. Thus, FRET analysis was performed with three channels: FRET, CFP and 
YFP. The FRET channel was defined by excitation ﬁlter 438/24 nm center 
wavelength/bandwidth, dichroic mirror with 458 nm edge wavelength, emission ﬁlter 542/27 
nm. Similarly, the CFP channel ﬁlter parameters were excitation 438/24 nm, dichroic edge at 
458 nm, emission 483/32 nm. The YFP had an excitation ﬁlter 500/24 nm with a dichroic 
edge at 520 nm and an emission ﬁlter at 542/27 nm. The excitation was provided by EXFO 
X-Cite 120 metal halide lamp operated at 12% iris to reduce photobleaching. To minimize 
photobleaching the exposure times were kept at 20 ms using a camera high gain (typically 50 
to 100 on the scale 0-255) with images taken every 15 s. Data acquisition and analysis was 
automated using NI Labview. 
Fluorescence images were background-corrected by manual selection of cell-free regions. 
FRET analysis was based on mean values taken over regions of interest (ROI) within the 
cells or was carried out pixel by pixel. To account for slight cell movements that occur 
during the time lapse acquisition, the ROIs were automatically adjusted to track the same 
regions. ROIs were chosen randomly for each cell and a net FRET (nF) was calculated 
according to: bIaIInF CFPYFPFRET   where IFRET, IYFP and ICFP are fluorescence 
intensities in each ROI coefficients a and b are the norms of bleed-through to FRET channel 
from EYFP and ECFP, respectively (26). The coefficient a was determined as a fraction of 
yellow light excited by 438 nm light relative to 500 nm excitation when cells expressing only 
EYFP is used. Similarly, b is determined as a fraction, IFRET /ICFP, when cells expressing only 
ECFP are measured. For our system a = 0.32 and b = 0.47. 
In these experiments, the expression level of FRET biosensor varied from cell to cell. To 
reliably quantify FRET in cells independent of the expression levels of redox biosensor, the 
net FRET was normalized against expression levels of ECFP, and EYFP was calculated 
through CFPYFPFRET IInFN  /  as described elsewhere (26). This normalization 
procedure is seen to remove the stochastic variation in FRET from cell to cell. Moreover, we 
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observe that while the FRET channel accurately reflects the oxidative state of the cell, the 
dynamics in the recovery region exhibited a common increase in intensities in all channels. 
Net FRET, the amplitude of the response to oxidation, increased but an increase of the signal 
in the recovery region was also observed. The NFRET normalization removes this effect and 
we clearly observe the return to the original redox state found prior to the application of 
diamide. 
5.3 Results and Discussion 
5.3.1 Transfection of 161-Porcine Cells with Biosensor 
For FRET-based biosensor validations, I was primarily responsible for transfection of 
CHO, 161C and 161T cells with biosensors. Transfected CHO cells were typically used as 
the proof of principle (control cell line) while 161C and 161T cells were used to determine 
the differences in how the redox environment of normal verses tumorigenic cells responds to 
modulations in intracellular redox environment.   
I used a Nucleofector
R
 and the Nucleofection Optimization Kit to determine the best 
conditions for Transfection of 161 porcine cell lines. There were no previously published or 
recommended Nucleofector
R
 transfection settings for 161 porcine cells. This optimization 
process included several weeks of transfection iteration during which various settings and 
conditions were varied.  Also, time-dose response concentrations were determined for the 
antibiotic, G-418 sulfate. One day after transfection, I confirmed that the porcine cells were 
successfully transfected via fluorescent microscopy. Transfected cells were monitored and 
cultured in media supplemented with G-418 sulfate antibiotic for three weeks, after which 
they were sorted.  Cells were sorted into three populations based upon fluorescent intensity, 
R4 (lowest level), R5 (intermediate level), and R6 (highest level) (Figure 5.2) using a 
MoFlo
TM
 high-performance cell sorter. Figure 5.3 shows that the R4 & R5 cell populations 
are not significantly different from each other. However, the R6 cell population maintains the 
highest level of fluorescent intensity. After a number of failed attempts, I determined that 
161C cells were resistant to stable transfection with the complete FRET-biosensor, CY-RL7, 
as well as only the donor, CFP.  I was, however, able to transiently transfected them. These 
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transiently transfected 161C cells still at times may be useful to compare behavior of 
tumorigenic cells and normal cells. 
5.3.2 Validation of FRET-based Biosensors in vivo 
Flow Cytometry 
To determine the effectiveness of the CY-RL7 biosensor construct for measuring the 
redox environment of living cells, Dr. Kolossov used flow cytometry analysis to measure 
changes in FRET signals in response to oxidative (CDNB, diamide) and reductive (DTT) 
treatments (Figure 5.3). The FRET response was as expected. No change was observed when 
Figure 5.2. Transfection and Sorting of 161T cells. (a) Flow cytometry frequency histogram of transfected 161T 
cells sorted into three populations based upon fluorescent intensity, R4 (lowest level), R5 (intermediate level), and 
R6 (highest level); (b) bright field and (c) fluorescent image of transfected porcine 161T cells, from the R6 
populations. (x 10)  
(a)Label outside of the graph;  Scale bare in figure b?? 
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Figure 5.3. A bar graph demonstrating the response of CY-RL7 in CHO cells to oxidation and 
reduction. The FRET channel was normalized over YFP to account variations in fluorescence intensity 
among different experiments. Cells were treated with either 1 mM DTT, CDNB or diamide. Biosensors 
are fully reduced and become oxidized upon exposure to CDNB and diamide. (From Kolossov) 
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cells were treated with DTT, suggesting that biosensors are fully reduced within these cells. 
Also, both CDNB and diamide yielded an increase in FRET. This demonstrates that 
biosensors transitioned from a fully reduced state to an oxidized state. Oxidation of the 
biosensor with CDNB also implies that the CY-RL7 biosensor is linked directly to the 
intracellular glutathione/glutathione disulfide redox couple. The bar graph (Figure 5.3) 
represents the geometric mean of each histogram averaged over four cell counting histograms 
from two experiments ± SD. 
Microscopy 
In most biological assays, FRET is measured using fluorescence microscopy (27).  
Conventional fluorescence microscopy was used to further investigate the effectiveness of 
the CY-RL7 construct for redox measurements in living cells. Dr. Kolossov demonstrated 
that the sensitivity of FRET-based biosensors in living cells is exclusively due to the nature 
of the redox linker (Figure 5.4a). In this work, the previously studied CY-P14 (12) construct 
was used as the negative control (Figure 5.4b). The P14 linker is only comprised of 14 
proline residues. To generate oxidative stress or a reducing environment, stably transfected 
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Figure 5.4. Time lapse response of (a) CY-RL7 sensor and (b) CY-P14 construct expressed in CHO cells to treatment 
with 1 mM diamide (vertical solid line) and DTT (vertical dashed line). Oxidation of biosensors is reversible. Sensitivity 
of FRET-based biosensors is exclusively due to the nature of the redox linker. (From Kolossov) 
(a) (b) 
CHO cells were treated with diamide or DTT respectively. The initial state of the CY-RL7 
biosensor (before oxidation) is characterized by low net FRET, which demonstrates that CY-
RL7 is fully reduced in accordance with the physiological state of the cell. Cell oxidation 
with diamide occurred very fast, in a time frame of seconds, which is evidenced by the rapid 
FRET increase of sensor CY-RL7 (Figure 5.5a). Upon treatment with DTT the net FRET 
value decreases. The negative control did not respond to diamide or DTT (Figure 5.5b). This 
result further confirms the usefulness of FRET-based biosensors for real-time measurements 
of the intracellular redox environment in living cells. Dr. Kolossov has also further supported 
the notion that biosensor conformational changes are fully reversible with experiments in 
which after three consecutive cycles of cell treatment (oxidation followed by reduction), the 
nF returned to its initial value. 
Microscopy: Normal vs. Tumorigenic Cells 
Using similar experimental protocols, I also worked with Dr. Tsvid and Dr. Li to further 
validate the usefulness of FRET-based biosensors and to understand how normal verse 
tumorigenic porcine cells recover in response to chemical agents that inhibit biosynthesis or 
metabolism of GSH. The response of transiently transfected 161C and 161T cells was 
monitored in response to exposure to diamide, after treatment with BSO and BCNU. 
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Figure 5.5. Differential recovery of isogenic control and nontransformed cells to perturbations of GSH homeostasis. 
Fluorescence  emission (538 nm) micrographs showing 161C and 161T cells transiently transfected with CY-RL7, 
imaged in a microfluidic channel at t = 0, just prior to a diamide (1 mM) treatment without pretreatment (a, a´),  after 
pretreatment with 0.5 mM BSO for 24 h (b, b´) or after 2 h of  0.5 mM BCNU pretreatment (c, c´). Corresponding 
ratiometric data of ROIs are presented in panels (d, d´) (without pretreatment); (e, e´) (BSO pretreatment); and (f, f´) 
(BCNU pretreatment). The solid vertical line indicates time of diamide application and the dashed vertical line 
indicates when the diamide washout. (With Lin, Tsvid, Kolossov) 
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Recovery was significantly delayed both by the inhibition of GSH biosynthesis by BSO; and 
the inactivation of glutathione reductase by BCNU (Figure 5.5). And, for the same exposure, 
the recovery time was twice as long in the tumorigenic cells. The data further demonstrate 
that FRET-based biosensors can offer insights into cancer cell physiology. The major 
outcome from these experiments is a comparison of the real-time kinetics of GSH depletion 
and recovery in normal and tumorigenic cells subjected to oxidant challenges. 
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5.4 Conclusions 
The most important advantage of the FRET-based biosensors described in this Chapter is 
the ability of these tools to monitor intracellular redox environment in living cells in real-
time. With the FRET-based biosensors, we hope to determine the phenotypic differences in 
glutathione homeostasis in normal verses tumorigenic cells. These FRET-based biosensors 
also show promise as a discovery tool for identifying novel cancer treatment methods. Dr. 
Kolossov has also developed biosensors that are not only active in the cytoplasm, but that can 
be localized in subcellular compartments such as the endoplasmic reticulum and the 
mitochondria.  
Although this work is promising, further optimization remains necessary.  One could 
envision improving the dynamic range and sensitivity of FRET-based biosensors such that 
redox modulations that accompany cellular events such as growth and apoptosis can be 
measured. This work also assumes that the cysteine thiol-based redox switches exhibit 
specificity toward the glutathione couple. This is supported by data; however, it is possible 
that there are other mechanisms at work that we have not yet elucidated, especially in the 
case of tumorigenic cells. Also, the use of transiently transfected 161 porcine control cells is 
not ideal, so the development of a stably transfected 161C cell line is needed. 
We also hope to integrate FRET biosensor technology with the ITO-based 
electrochemical platforms described in Chapter 3 for modulating intracellular redox 
environment in combination with in situ visualization of redox changes within individual 
cells, or even within individual cellular compartments through the use of redox biosensors 
with localization factors. Preliminary studies confirm the successful modulation of the 
intracellular redox environment of non-transfected cells seeded on ITO surfaces (Chapter 3). 
The electrochemical platforms are currently being optimized such that we can control 
environmental parameters (temperature, CO2), thereby creating the opportunity for robust 
and more versatile experiments that will aid in our quest to answer key biological questions 
in relation to redox regulation in cells. 
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Chapter 6 
Concluding Remarks and Future Directions 
6.1 Summary of Results and Conclusions  
Studies aimed at understanding the role of intracellular redox environment in cellular 
events have demonstrated that redox regulation is key (1, 2). However, traditional methods 
for both modulating and measuring intracellular redox environment have been successful yet 
somewhat limited due to limited selectivity and their potential to disrupt cellular homeostasis 
(3, 4). Methods with the ability to modulate and measure intracellular redox environment 
non-invasively and in real-time would be highly desired.  Such methods would enable the 
study of specific fundamental questions, such as: “To what extent have tumor cells lost the 
ability to either mount or sense changes in intracellular redox potential?” In this 
dissertation, I demonstrated the development and usefulness of novel, less invasive tools to 
modulate and measure intracellular redox environment in real time. 
Chapter 3 of this dissertation described the creation and validation of two electrochemical 
platforms that enable modulation of intracellular redox environment. In the first generation 
platform gold covered silicon was used as the working electrode, while in the second 
generation platform electrically conductive, transparent, indium tin oxide was the working 
electrode. Both electrochemical platforms were successful in oxidation and reduction of 
intracellular redox environment of Chinese hamster ovary cells, observed via flow cytometry. 
Cells seeded on platforms also remained viable (typically greater than 90%) after 
extracellular electric potential application.  
Chapter 4 presented the characterization of isogenic porcine cells.  Normal (161C) cells 
and tumorigenic cells (161T, 161T+p53) have phenotypic differences in morphology, growth 
rate, GSH content and intracellular redox potential.  161C cells are more fibroblast shaped 
than 161 tumorigenic cells which appear more rounded.  161C cells experience contact 
inhibition whereas tumorigenic cells do not and they tend to clump.  Also, as observed via 
growth curve analysis, tumorigenic cells were more proliferative than 161C cells. This may 
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be attributed to their more reduced intracellular redox potential.  The volume of 161C cells 
was also determined to be about three times greater than the volume of 161 tumorigenic cells.  
A key finding in this chapter is that like normal cells, the redox environment of tumorigenic 
cells is density-dependent and the redox potential of tumorigenic cells changes during stages 
of growth. 
Chapter 5 of this dissertation described novel FRET-based biosensors developed by Dr. 
Kolossov (5).  These biosensors were successfully transfected into Chinese hamster ovary 
cells as well as 161 cells. Biosensor validation was performed using transfected Chinese 
Hamster Ovary.  Dr. Kolossov demonstrated that oxidation of FRET-based biosensors is 
fully reversible and that FRET response is due to the nature of the redox sensitive linker.  
Also using 161 porcine cells we mapped real-time kinetics of GSH depletion and recovery in 
normal and tumorigenic cells.  Recovery time was significantly delayed when 161 cells were 
pretreated with either BSO (24 hours) or BCNU (2 hours). The recovery time was twice as 
long for 161T cells as it was for 161C.  
6.2 Future Directions 
Based on the results reported in this dissertation a number of future research directions 
can be foreseen: 
(i)  Further development and validation of next generation ITO-based electrochemical 
platforms (Chapter 3) for microscopy studies.  This will involve integrating FRET-
based biosensor technology with electrochemical platforms and model porcine cells 
for real-time, noninvasive modulating and measuring intracellular redox environment. 
(ii)       In my studies, I determined redox potential at two time points in the growth stage of 
161 cells (sparsely verses densely seeded). Observations of the redox potential of 
161C verses 161T cells during stages of cell growth will also prove important in 
understanding the time course changes of redox potential as cells progress from 
confluence to contact inhibition (or the lack their of--- tumorigenic cells). 
(iii)      Further validation of FRET-based biosensors is another avenue of future work related 
to this project.  Investigating whether the sensitivity and dynamic range of biosensors 
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allows for the measurement of redox environment during stages of cell growth will 
may further demonstrate the utility or the limitations of biosensors 
(iv)      Dr. Kolossov has also successfully developed biosensors that are specific to sub 
cellular compartments such as the endoplasmic reticulum and the mitochondria.  
These utility of these biosensors will add to our knowledge of both local and global 
intracellular redox.  
(v)  The development of a model for redox regulation of density-dependent redox 
regulation would solidify studies highlighted in Chapter 4. Hoffman et al. have 
suggested a model that supports our data (6). In this model they describe a threshold 
(oxidized) redox potential (-207 mV) that must be overcome by cells which promotes 
normal progression through the cell cycle (6). If this threshold potential is not 
reached, cells cannot enter into G0. The redox potential of 161 control cells cycles 
between -215 in sparsely seeded, proliferating cells and -171 mV in densely seeded, 
contact inhibited cells. This suggests that 161 control cells are capable of overcoming 
“threshold” redox potentials and thus traversing the cell cycle normally. Unlike 
Hoffman et al., we demonstrated that the redox potential of 161 tumorigenic cells 
[161T-p53 and 161 T (6 gene)] modulates during stages of cell growth, like normal 
cells.  Interestingly, the redox potential of these cells never became more negative 
(reduced) than the Hoffman suggested “threshold” redox potential.  Another aspect of 
the redox model may be related to cell volume and nuclear glutathione 
concentrations. For example, Markovic et al. suggest that cells need a reduced nuclear 
environment to proliferate (7).  Our studies suggest that cancerous cells indeed 
preserve their reducing capacity by having a nuclear to cytoplasmic volume ratio of 
about twice that of normal fibroblasts.   
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APPENDIX A 
Flow Cytometry Histograms from Chapter 3 
A.1 Live/Dead Studies 
For live/dead studies shown in Figure 3.2 and Figure 3.5 all raw data is located in 
Microsoft Excel files located on the Kenis Group server, computer “O2”, folder “Jerrod.” 
Files are labeled, and named after the specific study. For example, live dead studies are 
named “live-dead Au” or “live-dead ITO.”  Raw data is in column A. Raw data is labeled, 
PI-A, as in propidium iodide fluorescence. Raw data is converted to Bins (Bins 0 to 1024) 
which are in column B. Frequency is in column C. Frequency is calculated based upon the 
following spread sheet formula, Frequency = (Ax:Axx, B2:B1026) where x represents the 
first data point and xx represents the last data point in the raw data column, A. Data files are 
too large to include in this document. For example, raw data is typically 10,000 gated events 
while Bins and Frequency goes up to approximately 1,000 points. Frequency is plotted on the 
y-axis and Bins are plotted on the x-axis. Studies were conducted at the flow cytometry 
facility with the assistance of Dr. Barbara Pilas. 
A.2 Reduction and Oxidation on Gold 
Raw Data for Figure 3.3a is located in a Microsoft Excel file located on the Kenis Group 
server, computer “O2”, folder “Jerrod.” The file is named “Reduction on Gold.”  Data 
presented in Figure 3.3b is also located in a Microsoft Excel file named “Oxidation on 
Gold.” Raw data files are too large to include in this document. Column A represents raw 
data “MonoChloroBimane mBCL-A,” as in monochlorobimane relative fluorescence. 
Column B represents the Bin and column C the Frequency. The formula for frequency is, 
Frequency = (Ax:Axx, B2:B1026). Where x represents the first data point in the raw data 
column (A) and xx is the last data point. Column D is for visualization purposes. For 
example, in the case of 0 mV the plot was offset by 30 units so column D is frequency values 
in column C plus (+) 30. To obtain the curves presented as Figure 3.3a and Figure 3.3b data 
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was fit with a “moving average” trend line. The actual figure is shown within the worksheet. 
Studies were conducted at the flow cytometry facility with the assistance of Dr. Barbara 
Pilas. 
A.3 Reduction on ITO 
Raw Data for Figure 3.6 is located in a Microsoft Excel file located on the Kenis Group 
server, computer “O2”, folder “Jerrod.” The file is named “Reduction on ITO.” Again, data 
files are too large to include in this document. Column A is raw data “MonoChloroBimane 
mBCL-A.” Column B is the Bin and column C Frequency. The formula for Frequency is, 
Frequency = (Ax:Axx, B2:B1026). Where x represents the first raw data point in column A 
and xx is the last data point. Column D is for visualization purposes. For example, in the case 
of 0 mV the plot was offset by 30 units so column D is frequency values in column C plus 
(+) 30. To obtain the curve presented as Figure 3.6, data was fit with a “moving average” 
trend line. The actual figure is shown within the worksheet. Studies were conducted at the 
flow cytometry facility with the assistance of Dr. Barbara Pilas. 
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APPENDIX B 
Data Tables for Data Presented in Chapter 4 
B.1 Cell Volume Study  
Data for cell volume studies are shown below. Data for Figure 4.6 is located in a 
Microsoft Excel file located on the Kenis Group server, computer “O2”, folder “Jerrod.” The 
file is named “Cell Volume.” Volumes were determined using ImarisR Software at the Core 
Facility of the Institute for Genomic Biology with the assistance of Dr. Mayandi Sivaguru. 
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B.2 Cell Growth Study 
Data for cell growth studies are shown below. Data for Figure 4.7 is located in a 
Microsoft Excel file located on the Kenis Group server, computer “O2”, folder “Jerrod.” The 
file is named “Cell Growth.” For each growth curve N=3 
B.3 GSH Content Study 
Data for the GSH content study (Figure 4.8) can be found in a Microsoft Excel file 
located on the Kenis Group server, computer “O2”, folder “Jerrod.” The file is named “GSH 
Content.” For each data set, N is equal to 3 (N = 3). The GSH content per milligram protein 
is listed below. The calibration curve for milligrams of protein per milliliter is included in the 
same Microsoft Excel Worksheet. 
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B.4 Redox Potential Calculations 
Raw data is much too large to be included in this document in a legible manner. The raw 
data file named “Redox Potential” can be found in a Microsoft Excel file located on the 
Kenis Group server, computer “O2”, folder “Jerrod.” 
This file includes 3 worksheets. “Sheet 1” includes the HPLC measured peak areas and 
calculated peak area ratios.  Peak areas are converted to peak area ratios by dividing the peak 
area of the species of interest by the peak area of the internal standard, GSHee, for example, 
peak area of GSH/peak area of GSHee = peak area ratio.  “Sheet 2” includes the conversion 
of peak area ratios to concentration by substituting peak area ratios into calibration curves. 
Calibration curves are listed at the top of “Sheet 2.”  “Sheet 3” includes the Nernst equation 
calculation of the redox potential. The average concentrations ± SD and calculated redox 
potentials are included in Table B.4. Sparsely and densely seeded calculations are shown in 
the same “Sheet” and are clearly labeled.  
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